WO2022098810A1 - Assay support devices - Google Patents
Assay support devices Download PDFInfo
- Publication number
- WO2022098810A1 WO2022098810A1 PCT/US2021/057972 US2021057972W WO2022098810A1 WO 2022098810 A1 WO2022098810 A1 WO 2022098810A1 US 2021057972 W US2021057972 W US 2021057972W WO 2022098810 A1 WO2022098810 A1 WO 2022098810A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cover
- substrate
- base
- support device
- gasket
- Prior art date
Links
- 238000003556 assay Methods 0.000 title description 2
- 239000000758 substrate Substances 0.000 claims abstract description 387
- 238000000034 method Methods 0.000 claims description 47
- 238000010438 heat treatment Methods 0.000 claims description 29
- 239000011521 glass Substances 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 10
- 238000012546 transfer Methods 0.000 claims description 7
- 230000003213 activating effect Effects 0.000 claims description 3
- 239000000523 sample Substances 0.000 description 129
- 210000004027 cell Anatomy 0.000 description 57
- 210000001519 tissue Anatomy 0.000 description 40
- 239000012472 biological sample Substances 0.000 description 39
- 238000000576 coating method Methods 0.000 description 30
- 239000011248 coating agent Substances 0.000 description 28
- 239000012491 analyte Substances 0.000 description 23
- 239000000017 hydrogel Substances 0.000 description 23
- 239000000463 material Substances 0.000 description 18
- 210000002220 organoid Anatomy 0.000 description 18
- 241000124008 Mammalia Species 0.000 description 11
- 108091034117 Oligonucleotide Proteins 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 150000007523 nucleic acids Chemical class 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- -1 e.g. Substances 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
- 230000006835 compression Effects 0.000 description 8
- 238000007906 compression Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000011324 bead Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000012732 spatial analysis Methods 0.000 description 5
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 108091006146 Channels Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 238000012864 cross contamination Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 3
- 229910001887 tin oxide Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000239223 Arachnida Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 2
- 241000252212 Danio rerio Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- 102000007547 Laminin Human genes 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000008261 resistance mechanism Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000244202 Caenorhabditis Species 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000224495 Dictyostelium Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 201000006360 Edwards syndrome Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000004016 L-Type Calcium Channels Human genes 0.000 description 1
- 108090000420 L-Type Calcium Channels Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 201000009928 Patau syndrome Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241000233872 Pneumocystis carinii Species 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229920001872 Spider silk Polymers 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241001441722 Takifugu rubripes Species 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- 206010044686 Trisomy 13 Diseases 0.000 description 1
- 208000006284 Trisomy 13 Syndrome Diseases 0.000 description 1
- 208000007159 Trisomy 18 Syndrome Diseases 0.000 description 1
- 206010044688 Trisomy 21 Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000002669 amniocentesis Methods 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 241000617156 archaeon Species 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000003593 megakaryocyte Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 210000000581 natural killer T-cell Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000002501 natural regulatory T cell Anatomy 0.000 description 1
- 201000011682 nervous system cancer Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 201000003738 orofaciodigital syndrome VIII Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920005629 polypropylene homopolymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005488 sandblasting Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 206010053884 trisomy 18 Diseases 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L9/00—Supporting devices; Holding devices
- B01L9/52—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
- B01L3/50851—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates specially adapted for heating or cooling samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
- B01L3/50853—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates with covers or lids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0689—Sealing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/043—Hinged closures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/046—Function or devices integrated in the closure
- B01L2300/047—Additional chamber, reservoir
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/046—Function or devices integrated in the closure
- B01L2300/048—Function or devices integrated in the closure enabling gas exchange, e.g. vents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0609—Holders integrated in container to position an object
- B01L2300/0618—Holders integrated in container to position an object for removable separation walls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0822—Slides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0829—Multi-well plates; Microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0848—Specific forms of parts of containers
- B01L2300/0858—Side walls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
- B01L2300/123—Flexible; Elastomeric
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/12—Well or multiwell plates
Definitions
- Cells within a tissue of a subject have differences in cell morphology and/or function due to varied analyte levels (e.g., gene and/or protein expression) within the different cells.
- the specific position of a cell within a tissue e.g., the cell’s position relative to neighboring cells or the cell’s position relative to the tissue microenvironment
- imaging systems used on spatial analyte data are inherently variable in their resolution and sensitivity. This is due in large part to the variability of manufacturers for imaging system components in addition to the arrangement of the imaging apparatus, differences between various types of imaging apparatuses, and image acquisition software. The image quality is further impacted by alterations in the image acquisition performed by the user. This problem becomes more apparent when trying to image samples of an unknow n fluorescent intensity or by having samples imaged by users of varying experience.
- thermocyclers can be as part of polymerase chain reaction protocols for nucleic acid amplification and in transcription and reverse transcription analytical sequences.
- thermocyclers and other heating devices also can occur to facilitate temperature-sensitive reactions for restriction enzyme digestion and rapid diagnostics, for example.
- a biological sample may be placed on a solid support to be analyzed for identification or characterization of an analyte, such as DNA, RNA, or other genetic material, within the sample.
- Printed guides may help improve placement of a sample on a solid support.
- Embodiments disclosed below include support devices for substrates including a sample region and methods of incubating a sample disposed on a sample region of a substrate.
- a distinct advantage of the support devices and methods of the present disclosure is its construction as a one-piece device that provides ease of use to the user.
- the one-piece design facilitates set-up and reduces time spent by the user in assembling the device and substrate.
- the user can easily insert a substrate into the devices described without fastening multiple pieces.
- the user does not use any tools to aid in the insertion of the substrate into the device or to aid in removing the substrate from the device.
- the user may not need to use any type of fastener to assemble the support device or to secure a substrate to the support device, thereby providing a more efficient way of supporting a biological sample.
- the devices disclosed herein may alternatively use one or more fasteners to assemble the support device and/or to secure a substrate to the support device.
- another distinct advantage of the support devices and methods of the present disclosure is its design that provides access to a specific sample region in a substrate via alignment of the plurality of apertures in the substrate holder and the plurality of openings in the gasket.
- an additional advantage of the support devices and methods of the present disclosure is the uniform pressure applied to the substrate via the gasket and/or the rib or the plurality of ribs when the support device is in a closed position.
- a vapor-tight and/or air-tight seal is formed between the gasket and the substrate when the substrate holder is in the closed position. Such vapor-tight and/or air-tight seal can prevent transport of fluid between the plurality of openings of the gasket.
- the vapor-tight and/or air-tight seal can further prevent cross-contamination of biological samples via, e.g., the leakage of solution or fluid from a first sample region to a second sample region.
- Yet another advantage of the support devices and methods described in this disclosure is the minimization of shear forces on the substrate, for example, on the area of the substrate in proximity to the hinge or hinges. The minimization of shear forces can prevent damage to the substrate (e.g., breakage or cracking).
- the devices provided herein can provide consistent and even heating to a substrate surface. Even heating can be critical to ensuring that preparative reactions performed on a sample supported by the substrate occur according to established protocols and achieve desired outcomes.
- a substrate e.g., a glass slide
- Heating a substrate can cause condensation to form on an upper surface of an enclosed substrate well if the substrate is heated without an upper lid. Condensation can change the composition of reaction mixtures in the substrate wells, inhibiting preparative reactions, and/or producing unpredictable results.
- the devices described in this disclosure can be used to reduce or prevent condensation from forming in substrate wells via the vapor-tight and/or air-tight seal produced by the gasket.
- thermocyclers and heating devices are purpose-built for particular types of substrates such as multi-well substrates. Loading other types of substrates such as standard microscope slides into such devices can lead to uneven substrate heating.
- the devices described in this disclosure can be used to support substrates within heating devices that are not designed for such substrates, ensuring that adequate and even heat transfer occurs to the substrates.
- the devices can be used to adapt thermocyclers designed to accept multi-well substrates so that other types of substrates can be effectively heated within the thermocyclers as part of a sample preparation protocol.
- the devices of the disclosure allow a surface of the substrate to directly contact the surface of a heating device (e.g., a thermocycler), thereby permitting uniform heating throughout the substrate. That is, in some embodiments, no additional substrates or housing elements are required to be positioned in between the heat source and the substrates to be heated.
- a heating device e.g., a thermocycler
- the temperature of the substrate can be more easily controlled by the user and can be heated to a desired temperature in less time than when using devices that do not allow surface contact between the substrate and the heating device (e.g., a thermocycler).
- this disclosure is directed to a support device including: a substrate holder including: a cover including opposing first side walls, the cover configured to receive a gasket; a base including opposing first side walls, the base configured to receive a sample substrate; and a first locking tab and a second locking tab, the first locking tab and the second locking tab including moveable tabs coupled to the first side walls of one of the cover and the base and non-moveable tabs coupled to the first side walls of the other of the cover and the base, the first locking tab having a length greater than a length of the second locking tab, wherein the first locking tab extends along a length of the gasket, and wherein the moveable tabs are configured to engage with the non-moveable tabs to releasably secure the cover to the base.
- a height of the first locking tab is about equal to a height of the gasket. In some embodiments, the length of the first locking tab is about equal to the length of the gasket. In some embodiments, the device further includes at least one hinge and the at least one hinge extends from one of the second side walls of the cover to one of the second side walls of the base. In some embodiments, the at least one hinge is a breakable hinge. In some embodiments, the cover and the base are pivotably connected by the at least one hinge.
- the sample substrate rests on top of the base of the substrate holder.
- the cover includes a plurality of ribs extending from a surface of the cover, and the gasket is positionally aligned on the surface of the cover by the plurality of ribs.
- the gasket is positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, a vapor-tight seal is formed between the gasket and the sample substrate.
- the cover includes at least two apertures.
- the gasket includes at least two openings, wherein the at least two openings are positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, the at least two apertures are aligned with the at least two openings.
- the gasket is configured to prevent fluid transport between the at least two openings when the cover is in the closed position.
- the sample substrate is a glass slide.
- the base includes a lip extending around a perimeter of the base, the lip configured to retain the sample substrate within the base.
- the cover includes a plurality of ribs extending from a surface of the cover, and the sample substrate engages wi th at least one of the plurality of ribs when the substrate holder is in a closed position.
- the base includes an opening exposing at least a portion of the sample substrate when the sample substrate is placed in the base.
- each of the first side walls of the cover is generally orthogonal to the second side walls of the cover.
- the cover when the substrate holder is in a closed position, the cover is configured to fold onto the base.
- the length of the first locking tab is at least 90% of the length of the gasket, e.g., at least 75%, 80%, 90%, 100%, 120%, or at least 150% of the length of the gasket, from about 75% to about 150% of the length of the gasket.
- the length of the first locking tab relative to the length of the gasket is about 1:0.9 to about 1: 1.1, about 1:0.8 to about 1: 1.2, about 1:0.5 to about 1: 1.5.
- this disclosure is directed to a support device including: a substrate holder including: a cover including opposing first side walls and opposing second side walls, the cover configured to receive a gasket; a base including opposing first side walls and opposing second side walls, the base configured to receive a sample substrate, each of the first side walls of the base and the cover being longer than each of the second side walls of the base and the cover; and a locking tab including a moveable tab and a non-moveable tab, one of the moveable tab and the non-moveable tab coupled to one of the first side walls of the cover and another one of the moveable tab and the non-moveable tab coupled to one of the first side walls of the base, the locking tab having a length about equal to a length of the gasket, wherein the locking tab extends along the length of the gasket.
- the sample substrate rests on top of the base of the substrate holder.
- the cover includes a plurality of ribs extending from a surface of the cover, and the gasket is positionally aligned on the surface of the cover by the plurality of ribs.
- the gasket is positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, a vapor-tight seal is formed between the gasket and the sample substrate.
- the cover includes at least two apertures.
- the gasket includes at least two openings, wherein the at least two openings is positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, the at least two apertures is aligned with the at least two openings.
- the gasket is configured to prevent fluid transport between the at least two openings when the substrate holder is in the closed position.
- the sample substrate includes a glass slide.
- the base includes a lip extending around a perimeter of the base, the lip configured to retain the sample substrate within the base.
- the cover includes a plurality of ribs extending from a surface of the cover, and the sample substrate engages with at least one of the plurality of ribs when the substrate holder is in a closed position.
- the base includes an opening exposing at least a portion of the sample substrate when the sample substrate is placed in the base.
- the first side walls of the cover are generally orthogonal to the second side walls of the cover.
- the support device further includes at least one breakable hinge extending from one of the second side walls of the cover to one of the second side walls of the base such that, when the substrate holder is in a closed position, the cover is configured to fold onto the base to secure the sample substrate and the gasket between the cover and the base.
- the cover and the base are pivotably connected by at least one hinge extending from one of the second side walls of the cover to one of the second side walls of the base such that when the substrate holder is in the closed position, the cover configured to fold over the base to secure the sample substrate and the gasket between the cover and the base.
- the cover and the base are pivotably connected by the at least one breakable hinge.
- this disclosure is directed to a method of incubating a sample disposed on a sample region of a substrate, the method including: mounting the substrate on a base of a substrate holder of a support device, the substrate including the sample; moving a cover of the substrate holder toward the base of the substrate holder such that first and second moveable tabs on one of the base and the cover engage with first and second non-moveable tabs on the other of the base and the cover, the first moveable tab having a length greater than a length of the second moveable tab and extending along a length of a gasket received by the cover; positioning the substrate and the support device on a heating apparatus; and activating the heating apparatus to transfer heat to the sample.
- the substrate includes a glass slide. In some embodiments, when the substrate holder is coupled to the support device, at least 60% of the sample region is overlaid by the support device. In some embodiments, a height of the first moveable tab is about equal to a height of the gasket. In some embodiments, a length of the first moveable tab is about equal to a length of the gasket.
- each when used in reference to a collection of items, is intended to identify an individual item in the collection but does not necessarily refer to every item in the collection, unless expressly stated otherwise, or unless the context of the usage clearly indicates otherwise.
- FIG. 1 is a perspective view of an example support device in a closed position.
- FIG. 2 is a perspective view of the example support device of FIG. 1 in an open position.
- FIG. 3 is an exploded view of the example support device of FIG. 1.
- FIG. 4 is a perspective view of the example support device of FIG. 1 and a substrate.
- FIG. 5 is a perspective view of an example support device in a closed position.
- Tissues and cells can be obtained from any source.
- tissues and cells can be obtained from single-cell or multicellular organisms (e.g., a mammal).
- Tissues and cells obtained from a mammal e.g., a human, often have varied analyte levels (e.g., gene and/or protein expression) which can result in differences in cell morphology and/or function.
- the position of a cell or a subset of cells (e.g., neighboring cells and/or non-neighboring cells) within a tissue can affect, e.g., the cell’s fate, behavior, morphology, and signaling and crosstalk with other cells in the tissue.
- Information regarding the differences in analyte levels (gene and/or protein expression) within different cells in a tissue of a mammal can also help physicians select or administer a treatment that will be effective and can allow researchers to identify and elucidate differences in cell morphology and/or cell function in the single-cell or multicellular organisms (e.g., a mammal) based on the detected differences in analyte levels within different cells in the tissue.
- Differences in analyte levels within different cells in a tissue of a mammal can also provide information on how tissues (e.g., healthy and diseased tissues) function and/or develop.
- Differences in analyte levels within different cells in a tissue of a mammal can also provide information of different mechanisms of disease pathogenesis in a tissue and mechanism of action of a therapeutic treatment within a tissue. Differences in analyte levels within different cells in a tissue of a mammal can also provide information on drug resistance mechanisms and the development of the same in a tissue of a mammal. Differences in the presence or absence of analytes within different cells in a tissue of a multicellular organism (e.g., a mammal) can provide information on drug resistance mechanisms and the development of the same in a tissue of a multicellular organism.
- the support devices provided herein can be used with spatial analysis methodologies that provide a vast amount of analyte level and/or expression data for a variety of multiple analytes within a sample at high spatial resolution, e.g., while retaining the native spatial context.
- Spatial analysis methods include, e.g., the use of a capture probe including a spatial barcode (e.g., a nucleic acid sequence that provides information as to the position of the capture probe on a substrate which correlates to a location within a cell or a tissue sample (e.g., mammalian cell or a mammalian tissue sample) and a capture domain that is capable of binding to an analyte (e.g., a protein and/or nucleic acid) produced by and/or present in a cell or a tissue.
- a spatial barcode e.g., a nucleic acid sequence that provides information as to the position of the capture probe on a substrate which correlates to a location within a cell or a tissue sample (e.g., mammalian cell or a mammalian tissue sample) and a capture domain that is capable of binding to an analyte (e.g., a protein and/or nucleic acid) produced by and/or present in a
- the binding of an analyte to a capture probe can be detected using a number of different methods, e.g., nucleic acid sequencing, fluorophore detection, nucleic acid amplification, detection of nucleic acid ligation, and/or detection of nucleic acid cleavage products.
- the detection is used to associate and correlate a specific spatial barcode with a specific analyte produced by and/or present at a certain location in a cell or tissue (e.g., a mammalian cell or tissue).
- Capture probes can be, e.g., attached to a surface, e.g., a solid array, a bead, or a coverslip. In some examples, capture probes are not attached to a surface. In some examples, capture probes can be encapsulated within, embedded within, or layered on a surface of a permeable composition (e.g., any of the substrates described herein). For example, capture probes can be encapsulated or disposed within a permeable bead (e.g., a gel bead).
- a permeable composition e.g., any of the substrates described herein.
- capture probes can be encapsulated within, embedded within, or layered on a surface of a substrate (e.g., any of the exemplary substrates described herein, such as a hydrogel or a porous membrane).
- a capture probe is attached to a substrate, for example the surface of a slide, the attachment can be either direct or indirect (e.g., via a linker).
- a cell or a tissue sample including a cell is contacted with capture probes attached to a substrate (e.g., a surface of a substrate), and the cell or tissue sample is permeabilized to allow analytes to be released from the cell and hybridize to the capture probes attached to the substrate.
- a substrate e.g., a surface of a substrate
- analytes released from the cell passively migrate to the substrate for hybridization to a capture probe (e.g., via gravity).
- analytes released from a cell can be actively directed to the capture probes attached to a substrate using a variety of methods, e.g., electrophoresis, chemical gradient, pressure gradient, fluid flow, or magnetic field.
- Non-limiting aspects of support devices are described in PCT/US2019/065100, the entire contents of which are incorporated herein by reference and can be used herein in any combination. Further non-limiting aspects of support devices are described herein.
- biological sample is a sample that can be obtained from a subject for analysis using any of a variety of techniques including, but not limited to, biopsy, surgery, and laser capture microscopy
- a biological sample can be obtained from non-mammalian organisms (e.g., a plant, an insect, an arachnid, a nematode (e.g., Caenorhabditis elegans), a fungus, an amphibian, or a fish (e.g., zebrafish)).
- a biological sample can be obtained from a prokaryote such as a bacterium, e.g., Escherichia coli.
- a biological sample can be obtained from a eukaryote, such as a patient derived organoid (PDO) or patient derived xenograft (PDX).
- the biological sample can include organoids, a miniaturized and simplified version of an organ produced in vitro in three dimensions that shows realistic micro-anatomy.
- Organoids can be generated from one or more cells from a tissue, embryonic stem cells, and/or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities.
- an organoid is a cerebral organoid, an intestinal organoid, a stomach organoid, a lingual organoid, a thyroid organoid, a thymic organoid, a testicular organoid, a hepatic organoid, a pancreatic organoid, an epithelial organoid, a lung organoid, a kidney organoid, a gastruloid, a cardiac organoid, or a retinal organoid.
- Subjects from which biological samples can be obtained can be healthy or asymptomatic individuals, individuals that have or are suspected of having a disease (e.g., cancer) or a predisposition to a disease, and/or individuals that are in need of therapy or suspected of needing therapy.
- a disease e.g., cancer
- Bio samples can be derived from a homogeneous culture or population of the subjects or organisms mentioned herein or alternatively from a collection of several different organisms, for example, in a community or ecosystem.
- Biological samples can include one or more diseased cells.
- a diseased cell can have altered metabolic properties, gene expression, protein expression, and/or morphologic features. Examples of diseases include inflammatory disorders, metabolic disorders, nervous system disorders, and cancer. Cancer cells can be derived from solid tumors, hematological malignancies, cell lines, or obtained as circulating tumor cells.
- Biological samples can also include fetal cells.
- a procedure such as amniocentesis can be performed to obtain a fetal cell sample from maternal circulation.
- Sequencing of fetal cells can be used to identify any of a number of genetic disorders, including, e.g., aneuploidy such as Down’s syndrome, Edwards syndrome, and Patau syndrome.
- cell surface features of fetal cells can be used to identify any of a number of disorders or diseases.
- Biological samples can also include immune cells. Sequence analysis of the immune repertoire of such cells, including genomic, proteomic, and cell surface features, can provide a wealth of information to facilitate an understanding the status and function of the immune system.
- determining the status (e.g., negative or positive) of minimal residue disease (MRD) in a multiple myeloma (MM) patient following autologous stem cell transplantation is considered a predictor of MRD in the MM patient (see, e.g., U.S. Patent Application Publication No. 2018/0156784, the entire contents of which are incorporated herein by reference).
- immune cells in a biological sample include, but are not limited to, B cells, T cells (e.g., cytotoxic T cells, natural killer T cells, regulatory T cells, and T helper cells), natural killer cells, cytokine induced killer (CIK) cells, myeloid cells, such as granulocytes (basophil granulocytes, eosinophil granulocytes, neutrophil granulocytes/hypersegmented neutrophils), monocytes/macrophages, mast cells, thrombocytes/megakaryocytes, and dendritic cells.
- T cells e.g., cytotoxic T cells, natural killer T cells, regulatory T cells, and T helper cells
- natural killer cells e.g., cytokine induced killer (CIK) cells
- myeloid cells such as granulocytes (basophil granulocytes, eosinophil granulocytes, neutrophil granulocytes/hypersegmented neutrophils), monocytes
- the biological sample can include any number of macromolecules, for example, cellular macromolecules and organelles (e.g., mitochondria and nuclei).
- the biological sample can be a nucleic acid sample and/or protein sample.
- the biological sample can be a carbohydrate sample or a lipid sample.
- the biological sample can be obtained as a tissue sample, such as a tissue section, biopsy, a core biopsy, needle aspirate, or fine needle aspirate.
- the sample can be a fluid sample, such as a blood sample, urine sample, or saliva sample.
- the sample can be a skin sample, a colon sample, a cheek swab, a histology sample, a histopathology sample, a plasma or serum sample, a tumor sample, living cells, cultured cells, a clinical sample such as, for example, whole blood or blood-derived products, blood cells, or cultured tissues or cells, including cell suspensions.
- Cell-free biological samples can include extracellular polynucleotides.
- Extracellular polynucleotides can be isolated from a bodily sample, e.g., blood, plasma, serum, urine, saliva, mucosal excretions, sputum, stool, and tears.
- a biological sample can include a single analyte of interest, or more than one analyte of interest.
- the term “subject” is an animal, such as a mammal (e.g., human or a non-human simian), or avian (e.g., bird), or other organism, such as a plant.
- a mammal such as a rodent, mouse, rat, rabbit, guinea pig, ungulate, horse, sheep, pig, goat, cow, cat, dog, primate (i.e.
- a plant such as Arabidopsis thaliana, com, sorghum, oat, wheat, rice, canola, or soybean; an algae such as Chlamydomonas reinhardtii,' a nematode such as Caenorhabditis elegms an insect such as Drosophila melanogaster , mosquito, fruit fly, or honey bee; an arachnid such as a spider; a fish such as zebrafish; a reptile; an amphibian such as a frog or Xenopus laevis,' Dictyostelium discoideunp a fungus such as Pneumocystis carinii, Takifugu rubripes. yeast, Saccharamoyces cerevisiae or Schizosaccharomyces pombe or a Plasmodium falciparum.
- yeast Saccharamoyces cerevisiae or Schizosaccharomyces pom
- the biological sample can be attached to a substrate.
- substrates suitable for this purpose are described in detail below. Attachment of the biological sample can be irreversible or reversible, depending upon the nature of the sample and subsequent steps in the analytical method.
- the sample can be attached to the substrate reversibly by applying a suitable polymer coating to the substrate and contacting the sample to the polymer coating.
- the sample can then be detached from the substrate using an organic solvent that at least partially dissolves the polymer coating.
- Hydrogels are examples of polymers that are suitable for this purpose.
- the substrate can be coated or functionalized with one or more substances to facilitate attachment of the sample to the substrate.
- Suitable substances that can be used to coat or functionalize the substrate include, but are not limited to, lectins, poly-lysine, antibodies, and polysaccharides.
- a substrate For analytical methods using a substrate (e.g., spatial array-based analytical methods), the substrate functions as a support for direct or indirect attachment of capture probes to features of the array.
- a substrate e.g., the same substrate or a different substrate
- a substrate can be used to provide support to a biological sample, particularly, for example, a thin tissue section.
- a “substrate” is a support that is insoluble in aqueous liquid and which allows for positioning of biological samples, analytes, features, and/or capture probes on the substrate.
- Substrates can be formed from a variety of solid materials, gel-based materials, colloidal materials, semi-solid materials (e.g., materials that are at least partially cross-linked), materials that are fully or partially cured, and materials that undergo a phase change or transition to provide physical support.
- substrates examples include, but are not limited to, slides (e.g., slides formed from various glasses, slides formed from various polymers), hydrogels, layers and/or films, membranes (e.g., porous membranes), wafers, plates, or combinations thereof.
- substrates can optionally include functional elements such as recesses, protruding structures, microfluidic elements (e.g., channels, reservoirs, electrodes, valves, seals), and various markings, as will be discussed in further detail below.
- a substrate can generally have any suitable form or format that can be accommodated by the device disclosed herein.
- a substrate can be flat, curved, e.g., convexly or concavely curved towards the area where the interaction between a biological sample, e.g., tissue sample, and a substrate takes place.
- a substrate is flat, e.g., planar, chip, or slide.
- a substrate can contain one or more patterned surfaces within the substrate (e.g., channels, wells, projections, ridges, divots, etc.).
- a substrate can be of any desired shape.
- a substrate can be typically a thin, flat shape (e.g., a square or a rectangle).
- a substrate structure has rounded comers (e.g., for increased safety or robustness).
- a substrate structure has one or more cut-off comers (e.g., for use with a slide clamp or cross-table).
- the substrate stmcture can be any appropriate type of support having a flat surface (e.g., a chip or a slide such as a microscope slide).
- Substrates can optionally include various structures such as, but not limited to, projections, ridges, and channels.
- a substrate can be micropattemed to limit lateral diffusion (e.g., to prevent overlap of spatial barcodes).
- a substrate modified with such structures can be modified to allow association of analytes, features (e.g., specific locations where barcodes are deposited, beads), or probes at individual sites.
- the sites where a substrate is modified with various structures can be contiguous (e.g., the sites can be located within an area of the substrate that is enclosed by one of the gasket openings when the device is in a closed position) or non-contiguous with other sites (e.g., a first site can be located within a first area of the substrate that is enclosed by a first gasket opening and a second site can be located within a second area of the substrate that is enclosed by a second gasket opening when the support device is in a closed position).
- the surface of a substrate can be modified so that discrete sites are formed that can only have or accommodate a single feature.
- the surface of a substrate can be modified so that features are located at random sites (e.g., random sites within an area of the substrate that is enclosed by a gasket opening when the support device is in a closed position).
- the surface of a substrate is modified to contain one or more wells, using techniques such as (but not limited to) stamping, microetching, or molding techniques.
- the substrate in which a substrate includes one or more wells, can be a concavity slide or cavity slide.
- wells can be formed by one or more shallow depressions on the surface of the substrate.
- the wells can be formed by attaching a cassette (e.g., a cassette containing one or more chambers) to a surface of the substrate structure.
- the structures of a substrate can each bear one or more different capture probes. Different capture probes attached to each structure can be identified according to the locations of the structures in or on the surface of the substrate.
- Exemplary substrates include arrays in which separate structures are located on the substrate including, for example, those having wells or locations on the substate that accommodate features.
- the structures can include physically altered sites.
- a substrate modified with various structures can include physical properties, including, but not limited to, physical configurations, magnetic or compressive forces, chemically functionalized sites, chemically altered sites, and/or electrostatically altered sites.
- the structures are applied in a pattern. Alternatively, the structures can be randomly distributed.
- the substrate e g., or a bead or a feature on an array
- the substrate can include tens to hundreds of thousands or millions of individual oligonucleotide molecules (e.g., at least about 10,000, 50,000, 100,000, 500,000, 1,000,000, 10,000,000, 100,000,000, 1,000,000,000, or 10,000,000,000 oligonucleotide molecules).
- a substrate includes one or more markings on a surface of a substrate, e.g., to provide guidance for correlating spatial information with the characterization of the analyte of interest.
- a substrate can be marked with a grid of lines (e.g., to allow the size of objects seen under magnification to be easily eshmated and/or to provide reference areas for counting objects).
- fiducial markers can be included on a substrate. Such markings can be made using techniques including, but not limited to, printing, sandblasting, and depositing on the surface.
- a substrate can be any suitable support material that can be accommodated by the disclosed device.
- exemplary substrates include, but are not limited to, glass, modified and/or functionalized glass, hydrogels, films, membranes, plastics (including e.g., acrylics, polystyrene, copolymers of styrene and other materials, polypropylene, polyethylene, polybutylene, polyurethanes, TeflonTM, cyclic olefins, polyimides etc.), nylon, ceramics, resins, Zeonor, silica or silica-based materials including silicon and modified silicon, carbon, metals, inorganic glasses, optical fiber bundles, and polymers, such as polystyrene, cyclic olefin copolymers (COCs), cyclic olefin polymers (COPs), polypropylene, polyethylene polycarbonate, or combinations thereof.
- plastics including e.g., acrylics, polystyrene, copoly
- polystyrene is a hydrophobic material suitable for binding negatively charged macromolecules because it normally contains few hydrophilic groups.
- nucleic acids immobilized on glass slides by increasing the hydrophobicity of the glass surface the nucleic acid immobilization can be increased.
- Such an enhancement can permit a relatively more densely packed formation (e.g., provide improved specificity and resolution).
- the substrate can be a conductive substrate.
- Conductive substrates e.g., electrophoretic compatible arrays generated as described herein can be used in the spatial detection of analytes.
- a conductive substrate can include glass (e.g., a glass slide) that has been coated with a substance or otherwise modified to confer conductive properties to the glass.
- a glass slide can be coated with a conductive coating.
- a conductive coating includes tin oxide (TO) or indium tin oxide (ITO).
- a conductive coating includes a transparent conductive oxide (TOO).
- a conductive coating includes aluminum doped zinc oxide (AZO).
- a conductive coating includes fluorine doped tin oxide (FTO).
- arrays that are spotted or printed with oligonucleotides can be generated on a conductive substrate (e.g., any of the conductive substrates described herein).
- the arrays described herein can be compatible with active analyte capture methods (e.g., including without limitation, electrophoretic capture methods).
- a conductive substrate is a porous medium.
- porous media that can be used in methods that employ active analyte capture include a nitrocellulose or nylon membrane.
- a porous medium that can be used in methods described herein that employ active analyte capture includes paper.
- the oligonucleotides can be printed on a paper substrate.
- the printed oligonucleotides can interact with the substrate (e.g., interact with fibers of the paper).
- printed oligonucleotides can covalently bind the substrate (e.g., to fibers of the paper).
- oligonucleotides in a molecular precursor solution can be printed on a conductive substrate (e.g., paper).
- a molecular precursor solution can polymerize, thereby generating gel pads on the conductive substrate (e.g., paper).
- a molecular precursor solution can be polymerized by light (e.g., photocured).
- gel beads containing oligonucleotides e.g., barcoded oligonucleotides such as capture probes
- a conductive substrate e.g., paper
- the printed oligonucleotides can be covalently attached into the gel matrix.
- a surface of a substrate can be coated with a cell-permissive coating to allow adherence of live cells.
- a “cell-permissive coating” is a coating that allows or helps cells to maintain cell viability (e.g., remain viable) on the substrate.
- a cell-permissive coating can enhance cell attachment, cell grow th, and/or cell differentiation, e.g., a cell-permissive coating can provide nutrients to the live cells.
- a cell-permissive coating can include a biological material and/or a synthetic material.
- Non-limiting examples of a cell-permissive coating include coatings that feature one or more extracellular matrix (ECM) components (e.g., proteoglycans and fibrous proteins such as collagen, elastin, fibronectin and laminin), poly-lysine, poly(L)-omithine, and/or a biocompatible silicone (e.g., CYTOSOFT®).
- ECM extracellular matrix
- a cell-permissive coating that includes one or more extracellular matrix components can include collagen Type I, collagen Type II, collagen Type IV, elastin, fibronectin, laminin, and/or vitronectin.
- the cell- permissive coating includes a solubilized basement membrane preparation extracted from the Engelbreth-Holm- Swarm (EHS) mouse sarcoma (e.g., MATRIGEL®).
- the cell-permissive coating includes collagen.
- a cell-permissive coating can be used to culture adherent cells on a spatially-barcoded array, or to maintain cell viability of a tissue sample or section while in contact with a spatially -barcoded array.
- a substrate is coated with a surface treatment such as poly(L)- lysine.
- a surface treatment such as poly(L)- lysine.
- the substrate can be treated by silanation, e.g., with epoxy -silane, amino-silane, and/or by a treatment with polyacrylamide.
- a substrate is treated in order to minimize or reduce nonspecific analyte hybridization within or between features.
- treatment can include coating the substrate with a hydrogel, film, and/or membrane that creates a physical barrier to non-specific hybridization.
- Any suitable hydrogel can be used.
- hydrogel matrices prepared according to the methods set forth in U.S. Patent Nos. 6,391,937, 9,512,422, and 9,889,422, and U.S. Patent Application Publication Nos. U.S. 2017/0253918 and U.S. 2018/0052081 can be used. The entire contents of each of the foregoing documents is incorporated herein by reference.
- Treatment can include adding a functional group that is reactive or capable of being activated such that it becomes reactive after application of a stimulus (e.g., photoreactive functional groups).
- Treatment can include treating with polymers having one or more physical properties (e.g., mechanical, electrical, magnetic, and/or thermal) that minimize nonspecific binding (e.g., that activate a substrate at certain locations to allow analyte hybridization at those locations).
- a “removeable coating” is a coating that can be removed from the surface of a substrate upon application of a releasing agent.
- a removeable coating includes a hydrogel as described herein, e.g., a hydrogel including a polypeptide-based material.
- Non-limiting examples of a hydrogel featuring a polypeptide-based material include a synthetic peptide-based material featuring a combination of spider silk and a transmembrane segment of human muscle L-type calcium channel (e.g., PEPGEL®), an amphiphilic 16 residue peptide containing a repeating arginine-alanine-aspartate-alanine sequence (RAD ARAD ARAD ARADA) (e g., PURAMATRIX®), EAK16 (AEAEAKAKAEAEAKAK), KLD12 (KLDLKLDLKLDL), and PGMATRIXTM.
- PEPGEL® synthetic peptide-based material featuring a combination of spider silk and a transmembrane segment of human muscle L-type calcium channel
- RADA amphiphilic 16 residue peptide containing a repeating arginine-alanine-aspartate-alanine sequence
- PURAMATRIX® e g., PURAMATRIX®
- EAK16 AEAE
- the hydrogel in the removeable coating is a stimulus- responsive hydrogel.
- a stimulus-responsive hydrogel can undergo a gel-to-solution and/or gel-to-solid transition upon application of one or more external triggers (e.g., a releasing agent). See, e.g., Willner, Acc. Chem. Res. 50:657-658, 2017, which is incorporated herein by reference in its entirety.
- Non-limiting examples of a stimulus-responsive hydrogel include a thermoresponsive hydrogel, a pH-responsive hydrogel, a light-responsive hydrogel, a redox-responsive hydrogel, an analyte-responsive hydrogel, or a combination thereof.
- a stimulus-responsive hydrogel can be a multi-stimuli-responsive hydrogel.
- a “releasing agent” or “external trigger” is an agent that allows for the removal of a removeable coating from a substrate when the releasing agent is applied to the removeable coating.
- An external trigger or releasing agent can include physical triggers such as thermal, magnetic, ultrasonic, electrochemical, and/or light stimuli as well as chemical triggers such as pH, redox reactions, supramolecular complexes, and/or biocatalytically driven reactions. See e.g., Echeverria, et al., Gels (2016), 4, 54; doi: 10.3390/gels4020054, which is incorporated herein by reference in its entirety.
- the type of “releasing agent” or “external trigger” can depend on the type of removeable coating.
- a removeable coating featuring a redox-responsive hydrogel can be removed upon application of a releasing agent that includes a reducing agent such as dithiothreitol (DTT).
- a pH-responsive hydrogel can be removed upon the application of a releasing agent that changes the pH.
- the biological sample can be confined to a specific region or area.
- a biological sample can be affixed to a glass slide and a chamber, gasket, or cage positioned over the biological sample to act as a containment region or frame within which the biological sample is deposited.
- a support device can be part of a system (e.g., a system 3102, as described in PCT/US2019/065100, the entire contents of which are incorporated herein by reference) for heating a substrate that can further include a plate.
- the plate can be configured to be received by a heating device (e.g., a thermocycler) and provide heat transfer between the heating device and the support device.
- the support device e.g., a substrate holder 3150, as described in PCT/US2019/065100
- the support device can hold one or more substrates (such as one or more glass slides) and can removably couple to the plate to facilitate heat transfer from the plate to the one or more substrates.
- the support device can include a bottom member and a top member.
- the substrate device can further include a slide.
- the support device can include a gasket that is positioned inside the support device.
- the support device can include an engagement mechanism (e.g., screws) for coupling the bottom member and the top member.
- the support device can be a single-piece component (e.g., substrate holder 4400, as described in PCT/US2019/065100) that receives a gasket and a substrate.
- the support device can include one or more fasteners (such as a side mounted press latch 4410, as described in PCT/US2019/065100) for snap engagement of a substate.
- the support device can further include one or more tabs (e.g., first tab 4412a and second tab 4412b, as described in PCT/US2019/065100) that are configured to engage the substrate.
- the support device can include a bottom surface defining a plurality of apertures that are configured to align with a plurality of apertures of a gasket.
- the support device can include a top component and a bottom component that are connected via one or more hinges (e.g., hinge 7360, as described in PCT/US2019/065100) extending from a side wall of the bottom component.
- the support device can further include one or more engagement features protruding from a side wall of the top component (e.g., first notch 7358a and second notch 7358b, as described in PCT/US2019/06510), which are configured to engage one or more tabs protruding from a side wall of the bottom component, thereby enabling closure of the support device.
- Embodiments may provide one or more of the following advantages.
- the devices provided herein can be used to ensure that the temperature of a substrate and any samples and/or reagents supported on the substrate surface is controlled uniformly and consistently during a sample preparation and/or analysis protocol. During such protocols, uneven heating can lead to failure of the sample preparation. Further, even when sample heating is relatively uniform, condensation that contacts the sample may impair certain reactions that are part of the protocol, or otherwise affect the chemical reactions that occur.
- the devices described in various embodiments, provide for heating of multiple surfaces of a substrate (e.g., in a slide cassette or substrate holder), and can include features that facilitate heat transfer from heating elements to the substrate, and that can reduce or prevent condensation from forming in certain regions of the substrate (e.g., in sample wells or regions on the substrate surface).
- the devices provided herein can provide mitigation of cross-contamination of samples and/or reagents from different locations on the substrate.
- the described gaskets of the device can provide for discrete biological sample areas and a vapor barrier from one well to the next. Further, the gaskets can impede reagent spillage or flow from one well to the next.
- the devices provided herein include a locking that helps secure the gasket in place when the support device is in a closed position.
- an embodiment of an example support device can include a substrate and a substrate holder.
- the substrate holder can include a gasket, a cover, and a base.
- the cover and the base are integrally connected (e.g., the substrate holder is a one-part design).
- the substrate holder is manufactured using injection molding techniques. Non-limiting materials used to manufacture the support devices of the disclosure include polypropylene homopolymers.
- the substrate holder is disposable. In some embodiments, the substrate holder is reusable.
- the substrate holder receives a substrate, such as a slide, for example a glass slide.
- the substrate holder includes an attachment mechanism to couple and/or secure the substrate to the substrate holder.
- the cover can be configured to receive a gasket or can be co-molded with a gasket.
- the cover can include a plurality of ribs extending from a surface of the cover.
- the base can be configured to receive a substrate.
- the support device can further include at least one pair of locking tabs where each locking tab includes a moveable tab that is coupled to a first side wall of the cover and a non-moveable tab coupled to a first side wall of the base.
- each locking tab includes a moveable tab that is coupled to a first side wall of the base and a non-moveable tab is coupled to a first side wall of the cover.
- the moveable tab can be configured to engage with the non-moveable tab to releasably secure the cover to the base.
- a first locking tab of the pair of locking tabs has a length that is greater than the length of a second locking tab of the pair of locking tabs.
- the cover and the base are pivotably connected together by at least one hinge.
- the hinge can be a living hinge.
- the cover and the base are pivotably connected together by two or more hinges.
- at least one hinge extends from a second side wall of the cover to a second side wall of the base.
- the cover when the substrate holder is in a closed position, the cover can be configured to fold onto the base to secure the substrate and the gasket between the cover and the base.
- the pivotable connection can be broken at any stage, such that there is no longer a pivotable connection between the cover and the base.
- the support device can include a substrate (e.g., a glass slide) that is configured to receive a sample.
- the sample can be a biological sample.
- the sample can be any of the biological samples defined elsewhere in the disclosure.
- the substrate includes a first surface and a second surface.
- the first surface of the substrate is configured to receive a sample.
- the substrate includes a sample region. In some examples, the sample region receives one or more samples.
- FIG. 1 shows support device 100 in a closed position.
- Support device 100 includes a substrate holder 101 and a substrate 110.
- FIG. 1 shows the substrate holder 101 having a base 134 and a cover 136.
- Base 134 and cover 136 have a first pair of side walls 103 and a second pair of side walls 105. Each of the first side walls 103 can be longer than each of the second side walls 105.
- base 134 and cover 136 have a substantially rectangular shape.
- base 134 and cover 136 have a circular, square, triangular, or any other suitable shape.
- the first side wall 103 of the cover 136 is generally orthogonal to the second side wall 105 of the cover 136.
- first side wall 103 and the second side wall 105 of the cover 136 can form an angle between 85 and 95 degrees.
- the first side wall 103 of the base 134 is generally orthogonal to the second side wall 105 of the base 134.
- first side wall 103 and the second side wall 105 of the base 134 can form an angle between 85 and 95 degrees.
- the cover 136 includes a top surface 102 where a plurality of apertures 104 are defined through.
- the plurality of apertures 104 can be defined such that it aligns with a plurality of openings of a gasket when the gasket is positioned between the cover 136 and the base 134 in a closed position.
- the plurality of apertures 104 can be defined such that it aligns with a sample region of the substrate (e.g., a slide) when the support device is in a closed position.
- the plurality of apertures 104 can provide a user with access to the substrate (e g., a sample region on the substrate) to view a sample on the sample region and/or deliver a solution directly onto the sample on the sample region or onto a surface of the substrate, for example, when the support device is in a closed position.
- the substrate holder 101 can include at least one pair of locking tabs 107 that are configured to releasably secure, close, lock, fasten, and/or engage the base 134 with the cover 136.
- Each locking tab 107 can include a moveable tab 106 coupled to a first side wall 103 of the cover 136 and a non-moveable tab 108 coupled to a first side wall 103 of the base 134.
- the moveable tab 106 is configured to engage with the non-moveable tab 108 to releasably secure the cover 136 to the base 134.
- moveable tab 106 may be coupled to a second side wall 105 of the cover 136 and a non-moveable tab 108 may be coupled to a second side wall 105 of the base 134.
- one or more locking tabs 107 may be coupled to one or both first side walls 103 and/or one or more locking tabs 107 may be coupled to one or both second side walls 105.
- the moveable tabs 106 and the cover 136 are integrally joined.
- the moveable tabs 106 and the cover 136 can be formed as a single component in a molding, e.g., injection molding, process.
- the non-moveable tabs 108 and the base 134 are integrally joined.
- the non-moveable tabs 108 and the base 134 can be formed as a single component in a molding, e.g., injection molding, process.
- the substrate holder 101 can include multiple locking tabs 107 (e.g., at least 2, 3, 4, or 5 pairs of locking tabs 107).
- the substrate holder 101 includes one locking tab.
- any type of fastener that allows releasable engagement of the base 134 with the cover 136 can be used, such as, for example, magnetic fasteners, snap-fits, hook- and-loop fasteners, press latches, screws, press fit type connectors (e.g., lever, a clip, or a clamp), or any combination thereof.
- the substrate holder 101 can further include one or more spring-loaded fasteners.
- the substrate holder 101 can include a locking tab 158 that is configured to releasably secure, close, lock, fasten, and/or engage the base 134 with the cover 136.
- the locking tab 158 can include a moveable tab 162 coupled to a first side wall 103 of the cover 136 and a non-moveable tab 160 coupled to a first side wall 103 of the base 134.
- the moveable tab 162 is configured to engage with the non-moveable tab 160 to releasably secure the cover 136 to the base 134.
- the moveable tab 162 may be coupled to a second side wall 105 of the cover 136 and a non-moveable tab 160 may be coupled to a second side wall 105 of the base 134.
- one or more locking tabs 158 may be coupled to one or both first side walls 103 and/or one or more locking tabs 158 may be coupled to one or both second side walls 105.
- the moveable tab 162 and the cover 136 are integrally joined.
- the non- moveable tabs 160 and the base 134 are integrally joined.
- substrate holder 101 can include multiple locking tabs 158 (e.g., at least 2, 3, 4, or 5 locking tabs 158).
- the substrate holder 101 includes one locking tab 158 and one locking tab 107. In some embodiments, the substrate holder 101 includes one locking tab 158 and a pair of locking tabs 107. In some embodiments, the substrate holder 101 includes one locking tab 158 and three locking tabs 107. In some embodiments, the substrate holder 101 includes one locking tab 158 and four locking tabs 107.
- a surface of substrate 110 is exposed through a plurality of apertures 104 of the substrate holder 101.
- the plurality of apertures 104 are defined by the top surface 102 of cover 136.
- the plurality of apertures 104 align with the plurality of openings of the gasket when the support device 100 is in the closed position.
- FIG. 2 is a perspective view of the substrate holder 101 of FIG. 1 in an open position.
- the substrate holder 201 includes the locking tab 258 including a moveable tab 262 having a length Z m and a non-moveable tab 260 having a length In.
- the substrate holder 201 includes the pair of locking tabs 207 each including a moveable tab 206 having a length / ’ m and a non- moveable tab 208 having a length / ’ n .
- a length of the locking tab 258 can be greater than a length of the pair of locking tabs 207.
- the length Z m of the moveable tab 262 can be greater than the length / ’ m of the moveable tab 206.
- the length Z m of the moveable tab 262 can be about 40% greater than the length / ’ m of the moveable tab 206. In some embodiments, the length Zm of the moveable tab 262 can be at least about 10% to about 80% (e.g., between about 10% to 20%, 20% to 30%, 30% to 40%, 40% to 50%, 50% to 60%, 60% to 70%, or 70% to 80%) greater than the length Z ’ m of the moveable tab 206.
- the length Zn of the non-moveable tab 260 can be greater than the length Z ’ n of the non-moveable tab 208.
- the length Z n of the non-moveable tab 260 can be about 40% greater than the length Z’n of the non-moveable tab 208. In some embodiments, the length Z n of the moveable tab 260 can be at least about 10% to about 80% (e.g., between about 10% to 20%, 20% to 30%, 30% to 40%, 40% to 50%, 50% to 60%, 60% to 70%, or 70% to 80%) or more greater than the length Z’n of the moveable tab 208.
- the length Z m of the moveable tab 262 is about equal to the length Z g of the gasket 224 or the length Z g of the gasket 224. In some embodiments, the length Zm of the moveable tab 262 can be about 5% greater than the length Z g of the gasket 224. In some embodiments, the length Zm of the moveable tab 262 can be at least about 5% to about 20% (e.g., between about 5% to 10%, 10% to 15%, 15% to 20%) greater than the length Z g of the gasket 224. In some embodiments, the length Z m of the moveable tab 262 is aligned with a length Z g of the gasket 224.
- the length Z of the moveable tab 262 is at least 90% of the length Z g of the gasket 224, e.g., at least 75%, 80%, 90%, 100%, 120%, or at least 150% of the length Z g of the gasket 224, from about 75% to about 150% of the length Z g of the gasket 224.
- the length Z m of the moveable tab 262relative to the length Z g of the gasket 224 is about 1 :0.9 to about 1: 1.1, about 1 :0.8 to about 1: 1.2, about 1:0.5 to about 1 : 1.5.
- the length Z m of the moveable tab 262 can help secure the gasket 224 when substrate holder 201 is in a closed position such that a force is exerted onto gasket wall 209, along the length Z g of the gasket 224.
- moveable tab 262 is centered about the gasket 224 (e.g., centered along the length Z m of gasket 224).
- the relatively larger length of the locking tab 258 compared to the length of the locking tab 207 can allow the force exerted onto the gasket wall 209 to be more easily distributed across an entire length of the gasket 224.
- the relatively larger length of the locking tab 258 can allow a user to more easily manipulate the locking tab 258 (e.g., for locking or releasing the locking tab 258).
- the cover 236 and base 234 are pivotably connected by a pair of hinges 216 that extend from a second side wall 205 of the cover 236 to a second side wall 205 of the base 234.
- the pair of hinges can be a pair of living hinges.
- the cover and base are pivotably connected by at least one hinge.
- one or more hinges can extend from a second side wall of the cover to a second side wall of the base.
- the cover and the base can be pivotably connected by one hinge that has a length spanning about 50% or more of the length of the side from which it extends from.
- the cover and the base are pivotably connected by several hinges. In some embodiments, if there are hinges present the hinges are breakable, such that the cover and the base are separable upon breaking the one or more hinges.
- FIG. 2 shows the substrate holder 201 in an open position, having the cover 236 in an extended, unfolded position away from the base 234.
- the substrate holder 201 is in an open position when the cover 236 is at about 180° with respect to the base 234, as shown in FIG. 2.
- the substrate holder 201 is in an open position when the cover 236 is at an angle ranging from about 10° to about 170° with respect to the base 234.
- the cover 236 has a bottom surface 232 from which a plurality of ribs 218 can extend perpendicularly from. In some embodiments, the cover 236 is configured to receive the gasket 224. In some embodiments, a gasket 224 can withstand at least about 10% compression set. In some embodiments, the gasket 224 can withstand about 15% or more compression set. In some embodiments, the gasket 224 can withstand about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 40%, 60%, 70% or more compression set. As used herein, compression set is expressed as the percentage of the original specimen thickness after being exposed to a constant compressive force.
- the gasket 224 is co-molded with a portion of the substrate holder such as, for example, the cover 236.
- the gasket 224 can withstand a compression force that results in a gasket height hg change of about 0.5 millimeters (mm).
- the gasket 224 can withstand a compression force that results in a gasket height h & change of about 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1 mm or more.
- the gasket 224 is constructed out of a thermoplastic polymer, such as a thermoplastic elastomer.
- the gasket 224 removably adheres to the bottom surface 232 of the cover 236.
- the gasket 224 can include a plurality of openings 238.
- the plurality of openings 238 can align with the plurality of apertures 104 defined by the surface of the cover 236.
- the plurality of openings 238 is positioned so that when the substrate 110 (shown in FIG. 1) rests on top of the substrate holder 201, and the substrate holder 201 is in a closed position, the plurality of apertures 104 are aligned with the plurality of openings 238.
- the gasket 224 applies pressure on the substrate 210 when substrate holder 201 is in a closed position.
- the plurality of ribs 218 can be configured to support the substrate 210 and the gasket 224.
- the gasket 224 is positionally aligned on the surface of the cover 236 by the plurality of ribs. In some embodiments, the gasket 224 is positioned so that when the substrate 210 rests on top of the substrate holder 201, and the substrate holder 201 is in the closed position, a vapor-tight seal is formed between the gasket 224 and the substrate 210. In some embodiments, an air-tight seal is formed between the gasket 224 and the substrate 210. In some embodiments, the gasket 224 is configured to prevent fluid transport between the plurality of openings 238 when the cover 236 is in the closed position.
- Moveable tab 262 includes a top portion 268 extending from a substantially vertical wall 270 that further extends from the cover 236.
- the vertical wall 270 engages with the main body of the non-moveable tab 260 (e.g., its mating part) when the substrate holder 201 is in a closed position.
- the top portion 268 extends outwardly away from the main body of moveable tab 262 to form a gripping handle for the user.
- the gripping handle may facilitate pulling or pushing of moveable tab 262 by the user (e.g., when engaging and/or disengaging non-moveable tab 260).
- angle a can be about 15 degrees. In some embodiments, angle a can be at least about 5 degrees to about 90 degrees or more (e.g., between about 5 degrees to 10 degrees, 10 degrees to 15 degrees, 15 degrees to 20 degrees, 20 degrees to 25 degrees, 25 degrees to 30 degrees, 30 degrees to 35 degrees, 35 degrees to 40 degrees, 40 degrees to 45 degrees, 45 degrees to 50 degrees, 50 degrees to 55 degrees, 55 degrees to 60 degrees, 60 degrees to 65 degrees, 65 degrees to 70 degrees, 70 degrees to 75 degrees, 75 degrees to 80 degrees, 80 degrees to 85 degrees, 85 degrees to 90).
- a first height h m includes a top portion 268 and vertical wall 270 of moveable tab 262.
- a second height hv includes the vertical wall 270 of moveable tab 262.
- a first height h of the moveable tab 262 is about equal to the height hg of the gasket 224.
- the first height h of the moveable tab 262 can be about 5% greater than the height hg of the gasket 224.
- the first height hm of the moveable tab 262 can be at least about 5% to about 20% (e.g., between about 5% and 10%, 10% and 15%, 15% and 20%) greater than the height hg of the gasket 224.
- the first height hm of the moveable tab 262 can help secure the gasket 224 when substrate holder 201 is in a closed position such that a force is exerted onto the gasket wall 209 adjacent to the locking tab 258.
- a second height h of the moveable tab 262 can be about equal to the height hg of the gasket 224. In some embodiments, the second height h v of the moveable tab 262 can be about 5% greater than the height hg of the gasket 224. In some embodiments, the second height h? of the moveable tab 262 can be at least about 5% to about 20% (e.g., between about 5% and 10%, 10% and 15%, 15% and20%) greater than the height hg of the gasket 224. The second height h v of the moveable tab 262 can help secure the gasket 224 when substrate holder 201 is in a closed position such that a force is exerted onto the gasket wall 209 adjacent to the locking tab 258.
- the moveable tabs 206 each include a corresponding opening 281, and the moveable tab 262 includes an opening 282.
- the openings 281 and the opening 282 are vertically extended openings within which the non-moveable tabs 208, 260 engage with the moveable tabs 206 in the closed position of the substrate holder 201.
- the non-moveable tabs 208, 260 protrude horizontally outwardly from side walls of the base 234 (e.g., the first side wall 103 shown in FIG. 1).
- the non-moveable tabs 208, 260 protrude horizontally outward, the non-moveable tabs 208, 260 contact portions of the moveable tabs 206, 262 as the substrate holder 201 is moved from the open position (FIG. 2) to the closed position (FIG. 1).
- the non-moveable tabs 208 contact sloped portions 271 of the moveable tabs 206 and the non-moveable tabs 260 contact a sloped portion 272 of the moveable tab 262 as the cover 236 and the base 234 are brought toward one another to move the substrate holder 201 from the open position (FIG. 2) to the closed position (FIG. 1).
- This contact causes the moveable tabs 206, 262 to deflect outwardly, allowing the non-moveable tabs 208, 260 to move beyond the sloped portions 271, 272 of the moveable tabs 206, 262 into the openings 281, 282.
- the user can operate the gripping handle of the moveable tab 262.
- the moveable tabs 206, 262 return toward their neutral positions such that surfaces of the moveable tabs 206, 262 defining the openings 281, 282 are configured to contact the horizontally protruding portions of the non-moveable tabs 206, 262. This creates a locking engagement between the non-moveable tabs 208, 260 and the moveable tabs 206, 262 that prevents the base 234 and the cover 236 from being moved away from one another.
- the substrate holder 201 is in the closed position.
- the gasket 224 contacts (e.g., is compressed against) the substrate and provides a fluid tight seal between the sample regions of the substrate.
- the substrate holder 201 includes a plurality of ribs extending perpendicularly or protruding outwardly from bottom surface 232.
- the gasket 224 does not come in contact (i.e., does not abut) the plurality of ribs 218.
- the gasket is not co-molded with the cover.
- the gasket is mounted to the cover in another appropriate manner. In such embodiments, one or more ribs can be in proximity to or abut one or more gasket walls to help retain the gasket in a proper position.
- one or more ribs can be in proximity to or abut 1, 2, 3, or 4 of the gasket walls.
- the plurality of ribs 218 frame an area of the bottom surface 232 (e.g., an area that is sufficiently sized and configured to receive the gasket 224).
- the plurality of ribs 218 can be disposed parallel to the second side walls 205.
- the gasket is co-molded with the cover.
- the plurality of ribs 218 has a width w. In some embodiments, the plurality of ribs 218 can have an equal width w, as shown in FIG. 2. In some embodiments, the widths of the plurality of ribs 218 can vary. One of ribs 218 extends substantially perpendicular from bottom surface 232 near a first end 21 la of substrate holder 201. The remaining ribs 218 extend perpendicular from bottom surface 232 near a second end 211b of substrate holder 201. In some embodiments, the substrate holder 201 may include multiple ribs (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10 or more ribs). In some embodiments, the substrate holder 201 can include one or more ribs that extend perpendicular to the plurality of ribs 218.
- the plurality of ribs 218 has a height h.
- the plurality of nbs 218 can have an equal height h, as shown in FIG. 2.
- a height h can be provided such that the top edge of the plurality of ribs 218 comes in contact with substrate 110 (shown in FIG. 1) when the support device is in the closed position (FIG. 1).
- the contact between the plurality of ribs 218 and the substrate 110 can define a maximum amount of compression of the gasket 224. In particular, further compression of the gasket 224 can be prevented when the top edge of the plurality of ribs 218 contacts the substrate 110.
- the plurality of ribs 218 secures substrate 110 by coming in contact with a surface of substrate 110 when the support device is in the closed position (FIG. 1).
- the first surface 228 of the substrate 110 engages with at least one of the plurality of ribs 218 when the substrate holder 101 is in the closed position (FIG. 1).
- the first surface 228 of the substrate 110 includes a sample region.
- the sample region is an area of the substrate that is configured to receive one or more samples.
- substrate 110 includes one or more sample regions.
- FIG. 3 is an exploded view of an exemplary support device 300 in an open position.
- Cover 336 is configured to receive gasket 324.
- the cover 336 defines four holes 342 that receive four feet 344 of gasket 324.
- Each foot 344 projects from a bottom surface 366 of the gasket 324.
- each foot 344 projects from a comer of the gasket 324 (e.g., when two of the gasket walls 309 meet and form a right angle) or near a comer of the gasket 324.
- the feet 344 can be composed of a pliable or flexible material (e.g., a polymeric material such as silicone).
- the feet 344 have a circular base having a diameter that is larger than a diameter of the holes 342.
- the feet 344 are configured to partially or completely deform in shape when being introduced into the holes 342 such that once inserted, the feet 344 are secured and not easily removed due to the difference in diameters of the circular base of the feet 344 and the holes 342.
- the gasket 324 is permanently attached to the cover 336.
- gasket 224 can be reversibly attached to cover 336.
- Gasket 324 includes an L-shaped projection 326 extending from one of the gasket walls 309. In some embodiments, the L-shaped projection 326 extends from a comer of the gasket 324. In some embodiments, the L-shaped projection 326 is configured to be received by a recess 340 defined by the cover 336, In some embodiments, the recess 340 is an L- shaped recess. In some embodiments, the recess 340 has a shape that is complementary to the shape of the L-shaped projection 326.
- the cover 336 includes a plurality of T-shaped ribs 346 and cross-shaped ribs 348 extending perpendicularly or protruding outwardly from the bottom surface 332 of cover 336.
- the cover 336 includes eight T-shaped ribs 346.
- the cover 336 includes at least about one to about eight T-shaped ribs 346 (e.g., 1, 2, 3, 4, 5, 6, 7, or 8 T-shaped ribs 346).
- the T-shaped ribs 346 can extend perpendicularly or protrude outwardly from a portion of the bottom surface 332 that is aligned with the length / g of the gasket 324.
- the T-shaped ribs 346 can extend perpendicularly or protrude outwardly from a portion of the bottom surface 332 that is aligned with the width w g of the gasket 324.
- the cover 336 includes at least about one to about three cross-shaped ribs 348 (e.g., 1, 2 or 3 cross-shaped ribs 348).
- the cross-shaped ribs 348 can extend perpendicularly or protrude outwardly from a portion of the bottom surface 332 where four apertures 304 intersect.
- FIG. 4 is a perspective view of the support device 400 including the substrate holder 401 and the substrate 410.
- the substrate holder 401 is shown as having the cover 436 detached from the base 434.
- the pair of hinges 416 can be breakable hinges.
- the pair of hinges 416 are selectively, manually severable to permit a user to detach cover 436 from base 434.
- the pair of hinges 416 can include a breakable portion.
- the breakable portion can include breakable webbing.
- the pair of hinges 416 is irreversibly breakable. For example, once broken, the cover 436 and base 434 cannot be attached via the pair of hinges 416.
- the pair of hinges 416 may be reversibly breakable.
- the pair of hinges 416 may include first portions 450 and second portions 452 that can be configured to reversibly engage with one another.
- the first portions 450 of hinges 416 integrally extend from the cover 436 and the second portions 452 of hinge 416 integrally extend from the base 434.
- the first and second portions 450, 452 can be directly engaged to each other via a fastener (e.g., a snap fit, force fit, or male and female connections).
- a fastener e.g., a snap fit, force fit, or male and female connections.
- no hinges 416 are present on the device.
- one or more sample regions 464 defined on the first surface 428 of substrate 410 can fall within the enclosed area defined by each one of the plurality of openings 438 of gasket 424.
- substrate 410 may include samples (e.g., biological material samples) on a portion of its surface that align with one or more of the plurality of openings 438.
- the samples e.g., biological material samples
- the samples may be identified in the same manner as the corresponding aperture of the plurality of openings 438.
- the base 434 is configured to receive substrate 410.
- the cover 436 is configured to be placed on top of the base 434 to secure the substrate 410 and the gasket 424 between the cover 436 and the base 434.
- a user detaches the cover 436 from the base 434 before placing the substrate 410 in the base 434. Once detached, the user can insert the substrate 410 into the base 434 following the direction of the arrow 414. The user can place the cover 436 on top of the base 434 holding the substrate 410, e.g., in the direction of arrow 412, and snap the cover 436 onto the base 434 via the locking tabs 407 and 458 to secure the substrate 410.
- the second surface of the substrate 410 can rest on a portion of the base 434 of the substrate holder 401.
- base 434 can include a lip 422 configured to retain the substrate 410 within the base 434.
- substrate 410 can rest on lip 422 and be held in place.
- lip 422 extends around the perimeter of the base 434.
- the substrate can be secured to the base of the substrate holder.
- the substrate 410 can be placed in the base 434 in the direction of arrow 414.
- the second surface of substrate 410 can be placed such that it comes in contact with lip 222 and the first surface 428 of substrate 410 comes in contact with the plurality of ribs 418 and gasket 424 when the support device 400 is in a closed position.
- substrate 410 can be loaded into base 434 without using a tool.
- the base 434 can include an opening 420 sufficiently sized to expose one or more portions of the substrate 410.
- opening 420 is sized such that the majority of the second surface of substrate 410 is exposed and not covered.
- opening 420 can enable the second surface of substrate 410 to come in contact with a surface of a heating device (e g., a plate 3110, as described in PCT/US2019/065100, the entire contents of which are incorporated herein by reference).
- a heating device e g., a plate 3110, as described in PCT/US2019/065100, the entire contents of which are incorporated herein by reference.
- the first surface 428 of substrate 410 includes a sample region 464.
- the base 434 includes opening 420 that exposes at least a portion of the second surface of the substrate 410 when the substrate 410 is placed in the base 434.
- moveable tabs 406 and 458 can have a C-shape structure.
- moveable tabs 406 and 458 are constructed from a flexible material that enables them to be flexed away from the body of the substrate holder in order to engage the non-moveable tabs 408 and 462, respectively.
- non-moveable tabs 408 and 462 are unable to be flexed.
- non-moveable tabs 408 and 462 are rigid and do not flex when engaging the moveable tabs 406, 458.
- a first side wall 403 can measure about 3 inches. In some embodiments, a second side wall 405 can measure about 1 inch. In some embodiments, substrate 410 can measure about 75 millimeters (mm) by 25 mm. In some embodiments, substrate 410 can measure about 75 millimeters (mm) by 50 mm. In some embodiments, substrate 410 can measure about 48 millimeters (mm) by 28 mm. In some embodiments, substrate 410 can measure about 46 millimeters (mm) by 27 mm. In some embodiments, substrate 410 is a glass slide.
- a support device may be substantially similar in construction and function in several aspects to the support device 100, 200, 300, 400 discussed above, but can include an alternative number, size, and shape of apertures defined by the cover and an alternative number, size, and shape of gasket openings instead of the plurality of apertures 104, 304 and the plurality of openings 138, 238, 338, 438.
- the support device may have two apertures.
- the support device may have two gasket openings. Such difference between the number, size, and shape of apertures and gasket openings can allow a user to use the substrate holder to support substrates having a wide variety of number, size, and shape of sample regions defined on the surface of the substrate.
- FIG. 5 illustrates an example support device 500 in a closed position with two exemplary aperatures.
- the support device 500 includes a first aperture 554a and a second aperture 554b.
- the support device 500 includes two gasket openings that align with the first and second apertures 554a, 554b and enable portions of the substrate 510 to be exposed when the substrate holder 501 is in a closed position.
- the support device 500 can include a cover 536 defining 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, or more apertures.
- the support device 500 includes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, or more gasket openings.
- the support device 500 can include a cover 536 defining a number of apertures ranging between 1 and 4, between 4 and 8, between 8 and 16, or between 16 and 20. In some embodiments, the support device 500 includes a number of gasket openings ranging between 1 and 4, between 4 and 8, between 8 and 16, or between 16 and 20.
- the present disclosure includes a method of incubating a sample disposed on a sample region of any of the substrates disclosed herein.
- the method includes mounting the substrate on any of the support devices disclosed herein.
- the method further includes positioning the substrate and support device on a heating apparatus (e.g., a laboratory heat plate).
- the method further includes activating the heating apparatus to transfer heat to the sample (e.g., via the second surface of the substrate that is exposed via the opening of the substrate holder).
- a heating apparatus e.g., a laboratory heat plate
- the method further includes activating the heating apparatus to transfer heat to the sample (e.g., via the second surface of the substrate that is exposed via the opening of the substrate holder).
- at least 60% of a sample region is overlaid by the support device.
- at least 50%, 40%, 30%, 20%, 10% or less of a sample region of a substrate is overlaid by the support device.
- non-moveable tabs e.g., the nonmoveable tabs 108, 160, 208, 260, 408, 462
- the base e.g., the base 134, 234, 334, 434
- the moveable tabs e.g., the moveable tabs 106, 162, 206, 262, 406, 460
- the cover e.g., the cover 136, 236, 436
- the non-moveable tabs are on the cover and the moveable tabs are on the base.
- systems, apparatuses, and methods are disclosed herein, and it is understood that combinations, subsets, interactions, groups, etc. of these systems, apparatuses, and methods are disclosed. That is, while specific reference to each various individual and collective combinations and permutations of these systems, apparatuses and methods may not be explicitly disclosed, each is specifically contemplated and described herein.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
A support device includes a substrate holder including a cover configured to receive a gasket, a base configured to receive a sample substrate, and a first locking tab and a second locking tab. The first and second locking tabs includes moveable tabs coupled to opposing first side walls of one of the cover and the base and non-moveable tabs coupled to opposing first side walls of the other of the cover and the base. The first locking tab has a length greater than a length of the second locking tab. The first locking tab extends along a length of the gasket. The moveable tabs are configured to engage with the non-moveable tabs to releasably secure the cover to the base.
Description
ASSAY SUPPORT DEVICES
BACKGROUND
Cells within a tissue of a subject have differences in cell morphology and/or function due to varied analyte levels (e.g., gene and/or protein expression) within the different cells. The specific position of a cell within a tissue (e.g., the cell’s position relative to neighboring cells or the cell’s position relative to the tissue microenvironment) can affect, e.g., the cell’s morphology, differentiation, fate, viability, proliferation, behavior, and signaling and crosstalk with other cells in the tissue.
Spatial heterogeneity has been previously studied using techniques that only provide data for a small handful of analytes in the context of an intact tissue or a portion of a tissue, or provide a lot of analyte data for single cells, but fail to provide information regarding the position of the single cell in a parent biological sample (e.g., tissue sample).
Furthermore, imaging systems used on spatial analyte data are inherently variable in their resolution and sensitivity. This is due in large part to the variability of manufacturers for imaging system components in addition to the arrangement of the imaging apparatus, differences between various types of imaging apparatuses, and image acquisition software. The image quality is further impacted by alterations in the image acquisition performed by the user. This problem becomes more apparent when trying to image samples of an unknow n fluorescent intensity or by having samples imaged by users of varying experience.
Moreover, in a laboratory environment, a variety of processing protocols are used to prepare a sample for analysis. These protocols can be performed in test tubes, on slides, or more generally, on a sample that is supported by a substrate. Certain protocols are performed at stable, controlled temperatures to ensure the fidelity of the sample and protocol reagents. Other protocols involve temperature cycling and other steps in which the temperature of the sample is adjusted in a controlled fashion. To heat the sample and its supporting substrate during a protocol, a thermocycler, heating plate, or other heating device may be used. As one example, thermocyclers can be as part of polymerase chain reaction protocols for nucleic acid amplification and in transcription and reverse transcription analytical sequences. Controlled heating of samples in thermocyclers and other heating devices also can occur to facilitate temperature-sensitive reactions for restriction enzyme digestion and rapid diagnostics, for example.
In addition, a biological sample may be placed on a solid support to be analyzed for identification or characterization of an analyte, such as DNA, RNA, or other genetic material, within the sample. Printed guides may help improve placement of a sample on a solid support.
Current methods and devices to support biological samples (e.g., during spatial analysis and/or heating) often lack portability, do not provide access to specific sample regions or wells, and/or do not provide a vapor-tight seal for preventing cross-contamination between the sample regions or wells.
SUMMARY
Embodiments disclosed below include support devices for substrates including a sample region and methods of incubating a sample disposed on a sample region of a substrate. In some embodiments, a distinct advantage of the support devices and methods of the present disclosure is its construction as a one-piece device that provides ease of use to the user. For example, the one-piece design facilitates set-up and reduces time spent by the user in assembling the device and substrate. In some embodiments, the user can easily insert a substrate into the devices described without fastening multiple pieces. In some embodiments, the user does not use any tools to aid in the insertion of the substrate into the device or to aid in removing the substrate from the device. For example, the user may not need to use any type of fastener to assemble the support device or to secure a substrate to the support device, thereby providing a more efficient way of supporting a biological sample. In other examples, the devices disclosed herein may alternatively use one or more fasteners to assemble the support device and/or to secure a substrate to the support device.
In some embodiments, another distinct advantage of the support devices and methods of the present disclosure is its design that provides access to a specific sample region in a substrate via alignment of the plurality of apertures in the substrate holder and the plurality of openings in the gasket. In some embodiments, an additional advantage of the support devices and methods of the present disclosure is the uniform pressure applied to the substrate via the gasket and/or the rib or the plurality of ribs when the support device is in a closed position. Furthermore, a vapor-tight and/or air-tight seal is formed between the gasket and the substrate when the substrate holder is in the closed position. Such vapor-tight and/or air-tight seal can prevent transport of fluid between the plurality of openings of the gasket. The vapor-tight and/or air-tight seal can further prevent cross-contamination of biological samples via, e.g., the leakage of solution or fluid from a first sample region to a second sample region. Yet
another advantage of the support devices and methods described in this disclosure, in some embodiments, is the minimization of shear forces on the substrate, for example, on the area of the substrate in proximity to the hinge or hinges. The minimization of shear forces can prevent damage to the substrate (e.g., breakage or cracking).
The devices provided herein can provide consistent and even heating to a substrate surface. Even heating can be critical to ensuring that preparative reactions performed on a sample supported by the substrate occur according to established protocols and achieve desired outcomes.
Further, heating a substrate (e.g., a glass slide) to temperatures above room temperature can cause condensation to form on an upper surface of an enclosed substrate well if the substrate is heated without an upper lid. Condensation can change the composition of reaction mixtures in the substrate wells, inhibiting preparative reactions, and/or producing unpredictable results. The devices described in this disclosure can be used to reduce or prevent condensation from forming in substrate wells via the vapor-tight and/or air-tight seal produced by the gasket.
Certain types of thermocyclers and heating devices are purpose-built for particular types of substrates such as multi-well substrates. Loading other types of substrates such as standard microscope slides into such devices can lead to uneven substrate heating. The devices described in this disclosure can be used to support substrates within heating devices that are not designed for such substrates, ensuring that adequate and even heat transfer occurs to the substrates. In particular, the devices can be used to adapt thermocyclers designed to accept multi-well substrates so that other types of substrates can be effectively heated within the thermocyclers as part of a sample preparation protocol.
In some embodiments, the devices of the disclosure allow a surface of the substrate to directly contact the surface of a heating device (e.g., a thermocycler), thereby permitting uniform heating throughout the substrate. That is, in some embodiments, no additional substrates or housing elements are required to be positioned in between the heat source and the substrates to be heated. In addition, because the devices of the disclosure allow the surface of the substrate to directly contact the surface of a heating device (e.g., a thermocycler), the temperature of the substrate can be more easily controlled by the user and can be heated to a desired temperature in less time than when using devices that do not allow surface contact between the substrate and the heating device (e.g., a thermocycler). Thus, samples (e.g., a biological samples) on the substrate can be heated uniformly and in a controlled manner.
In one aspect, this disclosure is directed to a support device including: a substrate holder including: a cover including opposing first side walls, the cover configured to receive a gasket; a base including opposing first side walls, the base configured to receive a sample substrate; and a first locking tab and a second locking tab, the first locking tab and the second locking tab including moveable tabs coupled to the first side walls of one of the cover and the base and non-moveable tabs coupled to the first side walls of the other of the cover and the base, the first locking tab having a length greater than a length of the second locking tab, wherein the first locking tab extends along a length of the gasket, and wherein the moveable tabs are configured to engage with the non-moveable tabs to releasably secure the cover to the base.
In some embodiments, a height of the first locking tab is about equal to a height of the gasket. In some embodiments, the length of the first locking tab is about equal to the length of the gasket. In some embodiments, the device further includes at least one hinge and the at least one hinge extends from one of the second side walls of the cover to one of the second side walls of the base. In some embodiments, the at least one hinge is a breakable hinge. In some embodiments, the cover and the base are pivotably connected by the at least one hinge.
In some embodiments, the sample substrate rests on top of the base of the substrate holder. In some embodiments, the cover includes a plurality of ribs extending from a surface of the cover, and the gasket is positionally aligned on the surface of the cover by the plurality of ribs. In some embodiments, the gasket is positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, a vapor-tight seal is formed between the gasket and the sample substrate. In some embodiments, the cover includes at least two apertures.
In some embodiments, the gasket includes at least two openings, wherein the at least two openings are positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, the at least two apertures are aligned with the at least two openings. In some embodiments, the gasket is configured to prevent fluid transport between the at least two openings when the cover is in the closed position. In some embodiments, the sample substrate is a glass slide. In some embodiments, the base includes a lip extending around a perimeter of the base, the lip configured to retain the sample substrate within the base. In some embodiments, the cover includes a plurality of ribs extending from a surface of the cover, and the sample substrate engages wi th at least one of the plurality of ribs when the substrate holder is in a closed position. In some embodiments,
the base includes an opening exposing at least a portion of the sample substrate when the sample substrate is placed in the base.
In some embodiments, each of the first side walls of the cover is generally orthogonal to the second side walls of the cover. In some embodiments, when the substrate holder is in a closed position, the cover is configured to fold onto the base. In some embodiments, the length of the first locking tab is at least 90% of the length of the gasket, e.g., at least 75%, 80%, 90%, 100%, 120%, or at least 150% of the length of the gasket, from about 75% to about 150% of the length of the gasket. In some embodiments, the length of the first locking tab relative to the length of the gasket is about 1:0.9 to about 1: 1.1, about 1:0.8 to about 1: 1.2, about 1:0.5 to about 1: 1.5.
In another aspect, this disclosure is directed to a support device including: a substrate holder including: a cover including opposing first side walls and opposing second side walls, the cover configured to receive a gasket; a base including opposing first side walls and opposing second side walls, the base configured to receive a sample substrate, each of the first side walls of the base and the cover being longer than each of the second side walls of the base and the cover; and a locking tab including a moveable tab and a non-moveable tab, one of the moveable tab and the non-moveable tab coupled to one of the first side walls of the cover and another one of the moveable tab and the non-moveable tab coupled to one of the first side walls of the base, the locking tab having a length about equal to a length of the gasket, wherein the locking tab extends along the length of the gasket.
In some embodiments, the sample substrate rests on top of the base of the substrate holder. In some embodiments, the cover includes a plurality of ribs extending from a surface of the cover, and the gasket is positionally aligned on the surface of the cover by the plurality of ribs. In some embodiments, the gasket is positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, a vapor-tight seal is formed between the gasket and the sample substrate. In some embodiments, the cover includes at least two apertures. In some embodiments, the gasket includes at least two openings, wherein the at least two openings is positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, the at least two apertures is aligned with the at least two openings. In some embodiments, the gasket is configured to prevent fluid transport between the at least two openings when the substrate holder is in the closed position.
In some embodiments, the sample substrate includes a glass slide. In some embodiments, the base includes a lip extending around a perimeter of the base, the lip
configured to retain the sample substrate within the base. In some embodiments, the cover includes a plurality of ribs extending from a surface of the cover, and the sample substrate engages with at least one of the plurality of ribs when the substrate holder is in a closed position. In some embodiments, the base includes an opening exposing at least a portion of the sample substrate when the sample substrate is placed in the base. In some embodiments, the first side walls of the cover are generally orthogonal to the second side walls of the cover. In some embodiments, the support device further includes at least one breakable hinge extending from one of the second side walls of the cover to one of the second side walls of the base such that, when the substrate holder is in a closed position, the cover is configured to fold onto the base to secure the sample substrate and the gasket between the cover and the base. In some embodiments, the cover and the base are pivotably connected by at least one hinge extending from one of the second side walls of the cover to one of the second side walls of the base such that when the substrate holder is in the closed position, the cover configured to fold over the base to secure the sample substrate and the gasket between the cover and the base. In some embodiments, the cover and the base are pivotably connected by the at least one breakable hinge.
In another aspect, this disclosure is directed to a method of incubating a sample disposed on a sample region of a substrate, the method including: mounting the substrate on a base of a substrate holder of a support device, the substrate including the sample; moving a cover of the substrate holder toward the base of the substrate holder such that first and second moveable tabs on one of the base and the cover engage with first and second non-moveable tabs on the other of the base and the cover, the first moveable tab having a length greater than a length of the second moveable tab and extending along a length of a gasket received by the cover; positioning the substrate and the support device on a heating apparatus; and activating the heating apparatus to transfer heat to the sample.
In some embodiments, the substrate includes a glass slide. In some embodiments, when the substrate holder is coupled to the support device, at least 60% of the sample region is overlaid by the support device. In some embodiments, a height of the first moveable tab is about equal to a height of the gasket. In some embodiments, a length of the first moveable tab is about equal to a length of the gasket.
All publications, patents, patent applications, and information available on the internet and mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, patent application, or item of information was specifically and individually indicated to be incorporated by reference. To the extent
publications, patents, patent applications, and items of information incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material.
Where values are described in terms of ranges, it should be understood that the description includes the disclosure of all possible sub-ranges within such ranges, as well as specific numerical values that fall within such ranges irrespective of whether a specific numerical value or specific sub-range is expressly stated.
The term “each,” when used in reference to a collection of items, is intended to identify an individual item in the collection but does not necessarily refer to every item in the collection, unless expressly stated otherwise, or unless the context of the usage clearly indicates otherwise.
Various embodiments of the features of this disclosure are described herein. However, it should be understood that such embodiments are provided merely by way of example, and numerous variations, changes, and substitutions can occur to those skilled in the art without departing from the scope of this disclosure. It should also be understood that various alternatives to the specific embodiments described herein are also within the scope of this disclosure.
DESCRIPTION OF DRAWINGS
The following drawings illustrate certain embodiments of the features and advantages of this disclosure. These embodiments are not intended to limit the scope of the appended claims in any manner. Like reference symbols in the drawings indicate like elements.
FIG. 1 is a perspective view of an example support device in a closed position.
FIG. 2 is a perspective view of the example support device of FIG. 1 in an open position.
FIG. 3 is an exploded view of the example support device of FIG. 1.
FIG. 4 is a perspective view of the example support device of FIG. 1 and a substrate.
FIG. 5 is a perspective view of an example support device in a closed position.
DETAILED DESCRIPTION
I. Introduction
This disclosure describes devices and methods for spatial analysis of biological samples. This section describes certain general terminology, analytes, sample types, and preparative steps that are referred to in later sections of the disclosure.
1. Spatial Analysis
Tissues and cells can be obtained from any source. For example, tissues and cells can be obtained from single-cell or multicellular organisms (e.g., a mammal). Tissues and cells obtained from a mammal, e.g., a human, often have varied analyte levels (e.g., gene and/or protein expression) which can result in differences in cell morphology and/or function. The position of a cell or a subset of cells (e.g., neighboring cells and/or non-neighboring cells) within a tissue can affect, e.g., the cell’s fate, behavior, morphology, and signaling and crosstalk with other cells in the tissue. Information regarding the differences in analyte levels (gene and/or protein expression) within different cells in a tissue of a mammal can also help physicians select or administer a treatment that will be effective and can allow researchers to identify and elucidate differences in cell morphology and/or cell function in the single-cell or multicellular organisms (e.g., a mammal) based on the detected differences in analyte levels within different cells in the tissue. Differences in analyte levels within different cells in a tissue of a mammal can also provide information on how tissues (e.g., healthy and diseased tissues) function and/or develop. Differences in analyte levels within different cells in a tissue of a mammal can also provide information of different mechanisms of disease pathogenesis in a tissue and mechanism of action of a therapeutic treatment within a tissue. Differences in analyte levels within different cells in a tissue of a mammal can also provide information on drug resistance mechanisms and the development of the same in a tissue of a mammal. Differences in the presence or absence of analytes within different cells in a tissue of a multicellular organism (e.g., a mammal) can provide information on drug resistance mechanisms and the development of the same in a tissue of a multicellular organism.
The support devices provided herein can be used with spatial analysis methodologies that provide a vast amount of analyte level and/or expression data for a variety of multiple analytes within a sample at high spatial resolution, e.g., while retaining the native spatial context. Spatial analysis methods include, e.g., the use of a capture probe including a spatial barcode (e.g., a nucleic acid sequence that provides information as to the position of the capture probe on a substrate which correlates to a location within a cell or a tissue sample (e.g., mammalian cell or a mammalian tissue sample) and a capture domain that is capable of binding to an analyte (e.g., a protein and/or nucleic acid) produced by and/or present in a cell or a tissue.
The binding of an analyte to a capture probe can be detected using a number of different methods, e.g., nucleic acid sequencing, fluorophore detection, nucleic acid amplification, detection of nucleic acid ligation, and/or detection of nucleic acid cleavage products. In some examples, the detection is used to associate and correlate a specific spatial barcode with a specific analyte produced by and/or present at a certain location in a cell or tissue (e.g., a mammalian cell or tissue).
Capture probes can be, e.g., attached to a surface, e.g., a solid array, a bead, or a coverslip. In some examples, capture probes are not attached to a surface. In some examples, capture probes can be encapsulated within, embedded within, or layered on a surface of a permeable composition (e.g., any of the substrates described herein). For example, capture probes can be encapsulated or disposed within a permeable bead (e.g., a gel bead). In some examples, capture probes can be encapsulated within, embedded within, or layered on a surface of a substrate (e.g., any of the exemplary substrates described herein, such as a hydrogel or a porous membrane). When a capture probe is attached to a substrate, for example the surface of a slide, the attachment can be either direct or indirect (e.g., via a linker).
In some examples, a cell or a tissue sample including a cell is contacted with capture probes attached to a substrate (e.g., a surface of a substrate), and the cell or tissue sample is permeabilized to allow analytes to be released from the cell and hybridize to the capture probes attached to the substrate. In some examples, analytes released from the cell passively migrate to the substrate for hybridization to a capture probe (e.g., via gravity). In some examples, analytes released from a cell can be actively directed to the capture probes attached to a substrate using a variety of methods, e.g., electrophoresis, chemical gradient, pressure gradient, fluid flow, or magnetic field.
Non-limiting aspects of support devices are described in PCT/US2019/065100, the entire contents of which are incorporated herein by reference and can be used herein in any combination. Further non-limiting aspects of support devices are described herein.
(a) General Terminology
(i) Biological Samples
The devices and methods described in this disclosure can be used to support substrates configured to receive one or more biological samples. As used herein, “biological sample” is a sample that can be obtained from a subject for analysis using any of a variety of techniques including, but not limited to, biopsy, surgery, and laser capture microscopy
(LCM), and generally includes cells and/or other biological material from the subject, either
in suspension or as a tissue section from a tissue sample for example. In addition to the subjects described below, a biological sample can be obtained from non-mammalian organisms (e.g., a plant, an insect, an arachnid, a nematode (e.g., Caenorhabditis elegans), a fungus, an amphibian, or a fish (e.g., zebrafish)). A biological sample can be obtained from a prokaryote such as a bacterium, e.g., Escherichia coli. Staphylococci o Mycoplasma pneumoniae,' an archaeon; a virus such as Hepatitis C virus or human immunodeficiency virus; or a viroid. A biological sample can be obtained from a eukaryote, such as a patient derived organoid (PDO) or patient derived xenograft (PDX). The biological sample can include organoids, a miniaturized and simplified version of an organ produced in vitro in three dimensions that shows realistic micro-anatomy. Organoids can be generated from one or more cells from a tissue, embryonic stem cells, and/or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities. In some embodiments, an organoid is a cerebral organoid, an intestinal organoid, a stomach organoid, a lingual organoid, a thyroid organoid, a thymic organoid, a testicular organoid, a hepatic organoid, a pancreatic organoid, an epithelial organoid, a lung organoid, a kidney organoid, a gastruloid, a cardiac organoid, or a retinal organoid. Subjects from which biological samples can be obtained can be healthy or asymptomatic individuals, individuals that have or are suspected of having a disease (e.g., cancer) or a predisposition to a disease, and/or individuals that are in need of therapy or suspected of needing therapy.
Biological samples can be derived from a homogeneous culture or population of the subjects or organisms mentioned herein or alternatively from a collection of several different organisms, for example, in a community or ecosystem.
Biological samples can include one or more diseased cells. A diseased cell can have altered metabolic properties, gene expression, protein expression, and/or morphologic features. Examples of diseases include inflammatory disorders, metabolic disorders, nervous system disorders, and cancer. Cancer cells can be derived from solid tumors, hematological malignancies, cell lines, or obtained as circulating tumor cells.
Biological samples can also include fetal cells. For example, a procedure such as amniocentesis can be performed to obtain a fetal cell sample from maternal circulation. Sequencing of fetal cells can be used to identify any of a number of genetic disorders, including, e.g., aneuploidy such as Down’s syndrome, Edwards syndrome, and Patau syndrome. Further, cell surface features of fetal cells can be used to identify any of a number of disorders or diseases.
Biological samples can also include immune cells. Sequence analysis of the immune repertoire of such cells, including genomic, proteomic, and cell surface features, can provide a wealth of information to facilitate an understanding the status and function of the immune system. By way of example, determining the status (e.g., negative or positive) of minimal residue disease (MRD) in a multiple myeloma (MM) patient following autologous stem cell transplantation is considered a predictor of MRD in the MM patient (see, e.g., U.S. Patent Application Publication No. 2018/0156784, the entire contents of which are incorporated herein by reference).
Examples of immune cells in a biological sample include, but are not limited to, B cells, T cells (e.g., cytotoxic T cells, natural killer T cells, regulatory T cells, and T helper cells), natural killer cells, cytokine induced killer (CIK) cells, myeloid cells, such as granulocytes (basophil granulocytes, eosinophil granulocytes, neutrophil granulocytes/hypersegmented neutrophils), monocytes/macrophages, mast cells, thrombocytes/megakaryocytes, and dendritic cells.
The biological sample can include any number of macromolecules, for example, cellular macromolecules and organelles (e.g., mitochondria and nuclei). The biological sample can be a nucleic acid sample and/or protein sample. The biological sample can be a carbohydrate sample or a lipid sample. The biological sample can be obtained as a tissue sample, such as a tissue section, biopsy, a core biopsy, needle aspirate, or fine needle aspirate. The sample can be a fluid sample, such as a blood sample, urine sample, or saliva sample. The sample can be a skin sample, a colon sample, a cheek swab, a histology sample, a histopathology sample, a plasma or serum sample, a tumor sample, living cells, cultured cells, a clinical sample such as, for example, whole blood or blood-derived products, blood cells, or cultured tissues or cells, including cell suspensions.
Cell-free biological samples can include extracellular polynucleotides. Extracellular polynucleotides can be isolated from a bodily sample, e.g., blood, plasma, serum, urine, saliva, mucosal excretions, sputum, stool, and tears. A biological sample can include a single analyte of interest, or more than one analyte of interest.
(ii) Subject
As used herein, the term “subject” is an animal, such as a mammal (e.g., human or a non-human simian), or avian (e.g., bird), or other organism, such as a plant. Examples of subjects include, but are not limited to, a mammal such as a rodent, mouse, rat, rabbit, guinea pig, ungulate, horse, sheep, pig, goat, cow, cat, dog, primate (i.e. human or non-human primate); a plant such as Arabidopsis thaliana, com, sorghum, oat, wheat, rice, canola, or
soybean; an algae such as Chlamydomonas reinhardtii,' a nematode such as Caenorhabditis elegms an insect such as Drosophila melanogaster , mosquito, fruit fly, or honey bee; an arachnid such as a spider; a fish such as zebrafish; a reptile; an amphibian such as a frog or Xenopus laevis,' Dictyostelium discoideunp a fungus such as Pneumocystis carinii, Takifugu rubripes. yeast, Saccharamoyces cerevisiae or Schizosaccharomyces pombe or a Plasmodium falciparum.
(iii) Substrate Attachment
In some embodiments, the biological sample can be attached to a substrate. Examples of substrates suitable for this purpose are described in detail below. Attachment of the biological sample can be irreversible or reversible, depending upon the nature of the sample and subsequent steps in the analytical method.
In certain embodiments, the sample can be attached to the substrate reversibly by applying a suitable polymer coating to the substrate and contacting the sample to the polymer coating. The sample can then be detached from the substrate using an organic solvent that at least partially dissolves the polymer coating. Hydrogels are examples of polymers that are suitable for this purpose.
More generally, in some embodiments, the substrate can be coated or functionalized with one or more substances to facilitate attachment of the sample to the substrate. Suitable substances that can be used to coat or functionalize the substrate include, but are not limited to, lectins, poly-lysine, antibodies, and polysaccharides.
(iv) Substrates
For analytical methods using a substrate (e.g., spatial array-based analytical methods), the substrate functions as a support for direct or indirect attachment of capture probes to features of the array. In addition, in some embodiments, a substrate (e.g., the same substrate or a different substrate) can be used to provide support to a biological sample, particularly, for example, a thin tissue section. Accordingly, as used herein, a “substrate” is a support that is insoluble in aqueous liquid and which allows for positioning of biological samples, analytes, features, and/or capture probes on the substrate.
Further, a “substrate” as used herein, and when not preceded by the modifier “chemical,” refers to a member with at least one surface that generally functions to provide physical support for biological samples, analytes, and/or any of the other chemical and/or physical moieties, agents, and structures that can be used with various analytical methods. Substrates can be formed from a variety of solid materials, gel-based materials, colloidal
materials, semi-solid materials (e.g., materials that are at least partially cross-linked), materials that are fully or partially cured, and materials that undergo a phase change or transition to provide physical support. Examples of substrates that can be used in the methods and devices described herein include, but are not limited to, slides (e.g., slides formed from various glasses, slides formed from various polymers), hydrogels, layers and/or films, membranes (e.g., porous membranes), wafers, plates, or combinations thereof. In some embodiments, substrates can optionally include functional elements such as recesses, protruding structures, microfluidic elements (e.g., channels, reservoirs, electrodes, valves, seals), and various markings, as will be discussed in further detail below.
1) Substrate Attnbutes
A substrate can generally have any suitable form or format that can be accommodated by the device disclosed herein. For example, a substrate can be flat, curved, e.g., convexly or concavely curved towards the area where the interaction between a biological sample, e.g., tissue sample, and a substrate takes place. In some embodiments, a substrate is flat, e.g., planar, chip, or slide. A substrate can contain one or more patterned surfaces within the substrate (e.g., channels, wells, projections, ridges, divots, etc.).
A substrate can be of any desired shape. For example, a substrate can be typically a thin, flat shape (e.g., a square or a rectangle). In some embodiments, a substrate structure has rounded comers (e.g., for increased safety or robustness). In some embodiments, a substrate structure has one or more cut-off comers (e.g., for use with a slide clamp or cross-table). In some embodiments, where a substrate structure is flat, the substrate stmcture can be any appropriate type of support having a flat surface (e.g., a chip or a slide such as a microscope slide).
Substrates can optionally include various structures such as, but not limited to, projections, ridges, and channels. A substrate can be micropattemed to limit lateral diffusion (e.g., to prevent overlap of spatial barcodes). A substrate modified with such structures can be modified to allow association of analytes, features (e.g., specific locations where barcodes are deposited, beads), or probes at individual sites. For example, the sites where a substrate is modified with various structures can be contiguous (e.g., the sites can be located within an area of the substrate that is enclosed by one of the gasket openings when the device is in a closed position) or non-contiguous with other sites (e.g., a first site can be located within a first area of the substrate that is enclosed by a first gasket opening and a second site can be located within a second area of the substrate that is enclosed by a second gasket opening when the support device is in a closed position).
In some embodiments, the surface of a substrate can be modified so that discrete sites are formed that can only have or accommodate a single feature. In some embodiments, the surface of a substrate can be modified so that features are located at random sites (e.g., random sites within an area of the substrate that is enclosed by a gasket opening when the support device is in a closed position).
In some embodiments, the surface of a substrate is modified to contain one or more wells, using techniques such as (but not limited to) stamping, microetching, or molding techniques. In some embodiments in which a substrate includes one or more wells, the substrate can be a concavity slide or cavity slide. For example, wells can be formed by one or more shallow depressions on the surface of the substrate. In some embodiments, where a substrate includes one or more wells, the wells can be formed by attaching a cassette (e.g., a cassette containing one or more chambers) to a surface of the substrate structure.
In some embodiments, the structures of a substrate (e.g., wells or features) can each bear one or more different capture probes. Different capture probes attached to each structure can be identified according to the locations of the structures in or on the surface of the substrate. Exemplary substrates include arrays in which separate structures are located on the substrate including, for example, those having wells or locations on the substate that accommodate features.
In some embodiments where the substrate is modified to contain one or more structures, including but not limited to, wells, projections, ridges, features, or markings, the structures can include physically altered sites. For example, a substrate modified with various structures can include physical properties, including, but not limited to, physical configurations, magnetic or compressive forces, chemically functionalized sites, chemically altered sites, and/or electrostatically altered sites. In some embodiments where the substrate is modified to contain various structures, including but not limited to wells, projections, ridges, features, or markings, the structures are applied in a pattern. Alternatively, the structures can be randomly distributed.
The substrate (e g., or a bead or a feature on an array) can include tens to hundreds of thousands or millions of individual oligonucleotide molecules (e.g., at least about 10,000, 50,000, 100,000, 500,000, 1,000,000, 10,000,000, 100,000,000, 1,000,000,000, or 10,000,000,000 oligonucleotide molecules).
In some embodiments, a substrate includes one or more markings on a surface of a substrate, e.g., to provide guidance for correlating spatial information with the characterization of the analyte of interest. For example, a substrate can be marked with a grid
of lines (e.g., to allow the size of objects seen under magnification to be easily eshmated and/or to provide reference areas for counting objects). In some embodiments, fiducial markers can be included on a substrate. Such markings can be made using techniques including, but not limited to, printing, sandblasting, and depositing on the surface.
A wide variety of different substrates can be used for the foregoing purposes. In general, a substrate can be any suitable support material that can be accommodated by the disclosed device. Exemplary substrates include, but are not limited to, glass, modified and/or functionalized glass, hydrogels, films, membranes, plastics (including e.g., acrylics, polystyrene, copolymers of styrene and other materials, polypropylene, polyethylene, polybutylene, polyurethanes, Teflon™, cyclic olefins, polyimides etc.), nylon, ceramics, resins, Zeonor, silica or silica-based materials including silicon and modified silicon, carbon, metals, inorganic glasses, optical fiber bundles, and polymers, such as polystyrene, cyclic olefin copolymers (COCs), cyclic olefin polymers (COPs), polypropylene, polyethylene polycarbonate, or combinations thereof.
Among the examples of substrate materials discussed above, polystyrene is a hydrophobic material suitable for binding negatively charged macromolecules because it normally contains few hydrophilic groups. For nucleic acids immobilized on glass slides, by increasing the hydrophobicity of the glass surface the nucleic acid immobilization can be increased. Such an enhancement can permit a relatively more densely packed formation (e.g., provide improved specificity and resolution).
2) Conductive Substrates
In some embodiments, the substrate can be a conductive substrate. Conductive substrates (e.g., electrophoretic compatible arrays) generated as described herein can be used in the spatial detection of analytes.
In some embodiments, a conductive substrate can include glass (e.g., a glass slide) that has been coated with a substance or otherwise modified to confer conductive properties to the glass. In some embodiments, a glass slide can be coated with a conductive coating. In some embodiments, a conductive coating includes tin oxide (TO) or indium tin oxide (ITO). In some embodiments, a conductive coating includes a transparent conductive oxide (TOO). In some embodiments, a conductive coating includes aluminum doped zinc oxide (AZO). In some embodiments, a conductive coating includes fluorine doped tin oxide (FTO).
In some embodiments, arrays that are spotted or printed with oligonucleotides (e.g., capture probes) can be generated on a conductive substrate (e.g., any of the conductive
substrates described herein). For example, the arrays described herein can be compatible with active analyte capture methods (e.g., including without limitation, electrophoretic capture methods). In some embodiments, a conductive substrate is a porous medium. Non-limiting examples of porous media that can be used in methods that employ active analyte capture include a nitrocellulose or nylon membrane. In some embodiments, a porous medium that can be used in methods described herein that employ active analyte capture includes paper. In some embodiments, the oligonucleotides can be printed on a paper substrate. In some embodiments, the printed oligonucleotides can interact with the substrate (e.g., interact with fibers of the paper). In some embodiments, printed oligonucleotides can covalently bind the substrate (e.g., to fibers of the paper). In some embodiments, oligonucleotides in a molecular precursor solution can be printed on a conductive substrate (e.g., paper). In some embodiments, a molecular precursor solution can polymerize, thereby generating gel pads on the conductive substrate (e.g., paper). In some embodiments, a molecular precursor solution can be polymerized by light (e.g., photocured). In some embodiments, gel beads containing oligonucleotides (e.g., barcoded oligonucleotides such as capture probes) can be printed on a conductive substrate (e.g., paper). In some embodiments, the printed oligonucleotides can be covalently attached into the gel matrix.
3) Coatings
In some embodiments, a surface of a substrate can be coated with a cell-permissive coating to allow adherence of live cells. A “cell-permissive coating” is a coating that allows or helps cells to maintain cell viability (e.g., remain viable) on the substrate. For example, a cell-permissive coating can enhance cell attachment, cell grow th, and/or cell differentiation, e.g., a cell-permissive coating can provide nutrients to the live cells. A cell-permissive coating can include a biological material and/or a synthetic material. Non-limiting examples of a cell-permissive coating include coatings that feature one or more extracellular matrix (ECM) components (e.g., proteoglycans and fibrous proteins such as collagen, elastin, fibronectin and laminin), poly-lysine, poly(L)-omithine, and/or a biocompatible silicone (e.g., CYTOSOFT®). For example, a cell-permissive coating that includes one or more extracellular matrix components can include collagen Type I, collagen Type II, collagen Type IV, elastin, fibronectin, laminin, and/or vitronectin. In some embodiments, the cell- permissive coating includes a solubilized basement membrane preparation extracted from the Engelbreth-Holm- Swarm (EHS) mouse sarcoma (e.g., MATRIGEL®). In some embodiments, the cell-permissive coating includes collagen. A cell-permissive coating can be
used to culture adherent cells on a spatially-barcoded array, or to maintain cell viability of a tissue sample or section while in contact with a spatially -barcoded array.
In some embodiments, a substrate is coated with a surface treatment such as poly(L)- lysine. Additionally or alternatively, the substrate can be treated by silanation, e.g., with epoxy -silane, amino-silane, and/or by a treatment with polyacrylamide.
In some embodiments, a substrate is treated in order to minimize or reduce nonspecific analyte hybridization within or between features. For example, treatment can include coating the substrate with a hydrogel, film, and/or membrane that creates a physical barrier to non-specific hybridization. Any suitable hydrogel can be used. For example, hydrogel matrices prepared according to the methods set forth in U.S. Patent Nos. 6,391,937, 9,512,422, and 9,889,422, and U.S. Patent Application Publication Nos. U.S. 2017/0253918 and U.S. 2018/0052081, can be used. The entire contents of each of the foregoing documents is incorporated herein by reference.
Treatment can include adding a functional group that is reactive or capable of being activated such that it becomes reactive after application of a stimulus (e.g., photoreactive functional groups). Treatment can include treating with polymers having one or more physical properties (e.g., mechanical, electrical, magnetic, and/or thermal) that minimize nonspecific binding (e.g., that activate a substrate at certain locations to allow analyte hybridization at those locations).
A “removeable coating” is a coating that can be removed from the surface of a substrate upon application of a releasing agent. In some embodiments, a removeable coating includes a hydrogel as described herein, e.g., a hydrogel including a polypeptide-based material. Non-limiting examples of a hydrogel featuring a polypeptide-based material include a synthetic peptide-based material featuring a combination of spider silk and a transmembrane segment of human muscle L-type calcium channel (e.g., PEPGEL®), an amphiphilic 16 residue peptide containing a repeating arginine-alanine-aspartate-alanine sequence (RAD ARAD ARAD ARADA) (e g., PURAMATRIX®), EAK16 (AEAEAKAKAEAEAKAK), KLD12 (KLDLKLDLKLDL), and PGMATRIX™.
In some embodiments, the hydrogel in the removeable coating is a stimulus- responsive hydrogel. A stimulus-responsive hydrogel can undergo a gel-to-solution and/or gel-to-solid transition upon application of one or more external triggers (e.g., a releasing agent). See, e.g., Willner, Acc. Chem. Res. 50:657-658, 2017, which is incorporated herein by reference in its entirety. Non-limiting examples of a stimulus-responsive hydrogel include a thermoresponsive hydrogel, a pH-responsive hydrogel, a light-responsive hydrogel, a
redox-responsive hydrogel, an analyte-responsive hydrogel, or a combination thereof. In some embodiments, a stimulus-responsive hydrogel can be a multi-stimuli-responsive hydrogel.
A “releasing agent” or “external trigger” is an agent that allows for the removal of a removeable coating from a substrate when the releasing agent is applied to the removeable coating. An external trigger or releasing agent can include physical triggers such as thermal, magnetic, ultrasonic, electrochemical, and/or light stimuli as well as chemical triggers such as pH, redox reactions, supramolecular complexes, and/or biocatalytically driven reactions. See e.g., Echeverria, et al., Gels (2018), 4, 54; doi: 10.3390/gels4020054, which is incorporated herein by reference in its entirety. The type of “releasing agent” or “external trigger” can depend on the type of removeable coating. For example, a removeable coating featuring a redox-responsive hydrogel can be removed upon application of a releasing agent that includes a reducing agent such as dithiothreitol (DTT). As another example, a pH-responsive hydrogel can be removed upon the application of a releasing agent that changes the pH. In some embodiments, the biological sample can be confined to a specific region or area. For example, a biological sample can be affixed to a glass slide and a chamber, gasket, or cage positioned over the biological sample to act as a containment region or frame within which the biological sample is deposited.
SEQ ID NO: 7 GGTGACTCTAGATAACCT
2. Additional Support Device Embodiments
In some embodiments, a support device can be part of a system (e.g., a system 3102, as described in PCT/US2019/065100, the entire contents of which are incorporated herein by reference) for heating a substrate that can further include a plate. The plate can be configured to be received by a heating device (e.g., a thermocycler) and provide heat transfer between the heating device and the support device. The support device (e.g., a substrate holder 3150, as described in PCT/US2019/065100) can hold one or more substrates (such as one or more glass slides) and can removably couple to the plate to facilitate heat transfer from the plate to the one or more substrates. The support device can include a bottom member and a top member. In some embodiments, the substrate device can further include a slide. In some embodiments, the support device can include a gasket that is positioned inside the support device. In some embodiments, the support device can include an engagement mechanism (e.g., screws) for coupling the bottom member and the top member.
In some embodiments, the support device can be a single-piece component (e.g., substrate holder 4400, as described in PCT/US2019/065100) that receives a gasket and a
substrate. In some embodiments, the support device can include one or more fasteners (such as a side mounted press latch 4410, as described in PCT/US2019/065100) for snap engagement of a substate. In some embodiments, the support device can further include one or more tabs (e.g., first tab 4412a and second tab 4412b, as described in PCT/US2019/065100) that are configured to engage the substrate. The support device can include a bottom surface defining a plurality of apertures that are configured to align with a plurality of apertures of a gasket.
In some embodiments, the support device can include a top component and a bottom component that are connected via one or more hinges (e.g., hinge 7360, as described in PCT/US2019/065100) extending from a side wall of the bottom component. The support device can further include one or more engagement features protruding from a side wall of the top component (e.g., first notch 7358a and second notch 7358b, as described in PCT/US2019/06510), which are configured to engage one or more tabs protruding from a side wall of the bottom component, thereby enabling closure of the support device.
II. Support Devices
Embodiments may provide one or more of the following advantages.
The devices provided herein can be used to ensure that the temperature of a substrate and any samples and/or reagents supported on the substrate surface is controlled uniformly and consistently during a sample preparation and/or analysis protocol. During such protocols, uneven heating can lead to failure of the sample preparation. Further, even when sample heating is relatively uniform, condensation that contacts the sample may impair certain reactions that are part of the protocol, or otherwise affect the chemical reactions that occur. The devices described, in various embodiments, provide for heating of multiple surfaces of a substrate (e.g., in a slide cassette or substrate holder), and can include features that facilitate heat transfer from heating elements to the substrate, and that can reduce or prevent condensation from forming in certain regions of the substrate (e.g., in sample wells or regions on the substrate surface). Additionally, the devices provided herein can provide mitigation of cross-contamination of samples and/or reagents from different locations on the substrate. For example, the described gaskets of the device can provide for discrete biological sample areas and a vapor barrier from one well to the next. Further, the gaskets can impede reagent spillage or flow from one well to the next. In some embodiments, the devices provided herein
include a locking that helps secure the gasket in place when the support device is in a closed position.
Referring generally to FIGS. 1-4, an embodiment of an example support device can include a substrate and a substrate holder. The substrate holder can include a gasket, a cover, and a base. In some embodiments, the cover and the base are integrally connected (e.g., the substrate holder is a one-part design). In some embodiments, the substrate holder is manufactured using injection molding techniques. Non-limiting materials used to manufacture the support devices of the disclosure include polypropylene homopolymers. In some embodiments, the substrate holder is disposable. In some embodiments, the substrate holder is reusable.
In some embodiments, the substrate holder receives a substrate, such as a slide, for example a glass slide. In some embodiments, the substrate holder includes an attachment mechanism to couple and/or secure the substrate to the substrate holder. The cover can be configured to receive a gasket or can be co-molded with a gasket. The cover can include a plurality of ribs extending from a surface of the cover. Furthermore, the base can be configured to receive a substrate. In some examples, the support device can further include at least one pair of locking tabs where each locking tab includes a moveable tab that is coupled to a first side wall of the cover and a non-moveable tab coupled to a first side wall of the base. In other examples, each locking tab includes a moveable tab that is coupled to a first side wall of the base and a non-moveable tab is coupled to a first side wall of the cover. The moveable tab can be configured to engage with the non-moveable tab to releasably secure the cover to the base. In some embodiments, a first locking tab of the pair of locking tabs has a length that is greater than the length of a second locking tab of the pair of locking tabs.
In some examples, the cover and the base are pivotably connected together by at least one hinge. In some embodiments, the hinge can be a living hinge. In some embodiments, the cover and the base are pivotably connected together by two or more hinges. In some embodiments, at least one hinge extends from a second side wall of the cover to a second side wall of the base. For example, when the substrate holder is in a closed position, the cover can be configured to fold onto the base to secure the substrate and the gasket between the cover and the base. In some embodiments, the pivotable connection can be broken at any stage, such that there is no longer a pivotable connection between the cover and the base.
Moreover, the support device can include a substrate (e.g., a glass slide) that is configured to receive a sample. In some embodiments, the sample can be a biological sample. In some embodiments, the sample can be any of the biological samples defined elsewhere in
the disclosure. The substrate includes a first surface and a second surface. In some examples, the first surface of the substrate is configured to receive a sample. In some embodiments, the substrate includes a sample region. In some examples, the sample region receives one or more samples.
FIG. 1 shows support device 100 in a closed position. Support device 100 includes a substrate holder 101 and a substrate 110. In particular, FIG. 1 shows the substrate holder 101 having a base 134 and a cover 136. Base 134 and cover 136 have a first pair of side walls 103 and a second pair of side walls 105. Each of the first side walls 103 can be longer than each of the second side walls 105. Thus, base 134 and cover 136 have a substantially rectangular shape. In some embodiments, base 134 and cover 136 have a circular, square, triangular, or any other suitable shape. In some embodiments, the first side wall 103 of the cover 136 is generally orthogonal to the second side wall 105 of the cover 136. For example, the first side wall 103 and the second side wall 105 of the cover 136 can form an angle between 85 and 95 degrees. In some embodiments, the first side wall 103 of the base 134 is generally orthogonal to the second side wall 105 of the base 134. For example, the first side wall 103 and the second side wall 105 of the base 134 can form an angle between 85 and 95 degrees. The cover 136 includes a top surface 102 where a plurality of apertures 104 are defined through. In some embodiments, the plurality of apertures 104 can be defined such that it aligns with a plurality of openings of a gasket when the gasket is positioned between the cover 136 and the base 134 in a closed position. In some embodiments, the plurality of apertures 104 can be defined such that it aligns with a sample region of the substrate (e.g., a slide) when the support device is in a closed position. In some embodiments, the plurality of apertures 104 can provide a user with access to the substrate (e g., a sample region on the substrate) to view a sample on the sample region and/or deliver a solution directly onto the sample on the sample region or onto a surface of the substrate, for example, when the support device is in a closed position.
The substrate holder 101 can include at least one pair of locking tabs 107 that are configured to releasably secure, close, lock, fasten, and/or engage the base 134 with the cover 136. Each locking tab 107 can include a moveable tab 106 coupled to a first side wall 103 of the cover 136 and a non-moveable tab 108 coupled to a first side wall 103 of the base 134. In some embodiments, the moveable tab 106 is configured to engage with the non-moveable tab 108 to releasably secure the cover 136 to the base 134. In alternative examples, moveable tab 106 may be coupled to a second side wall 105 of the cover 136 and a non-moveable tab 108 may be coupled to a second side wall 105 of the base 134. In some embodiments, one or
more locking tabs 107 may be coupled to one or both first side walls 103 and/or one or more locking tabs 107 may be coupled to one or both second side walls 105. In some embodiments, the moveable tabs 106 and the cover 136 are integrally joined. For example, the moveable tabs 106 and the cover 136 can be formed as a single component in a molding, e.g., injection molding, process. In some embodiments, the non-moveable tabs 108 and the base 134 are integrally joined. For example, the non-moveable tabs 108 and the base 134 can be formed as a single component in a molding, e.g., injection molding, process. In some examples, the substrate holder 101 can include multiple locking tabs 107 (e.g., at least 2, 3, 4, or 5 pairs of locking tabs 107). In some embodiments, the substrate holder 101 includes one locking tab. In some embodiments, any type of fastener that allows releasable engagement of the base 134 with the cover 136 can be used, such as, for example, magnetic fasteners, snap-fits, hook- and-loop fasteners, press latches, screws, press fit type connectors (e.g., lever, a clip, or a clamp), or any combination thereof. In some embodiments, the substrate holder 101 can further include one or more spring-loaded fasteners.
The substrate holder 101 can include a locking tab 158 that is configured to releasably secure, close, lock, fasten, and/or engage the base 134 with the cover 136. The locking tab 158 can include a moveable tab 162 coupled to a first side wall 103 of the cover 136 and a non-moveable tab 160 coupled to a first side wall 103 of the base 134. In some embodiments, the moveable tab 162 is configured to engage with the non-moveable tab 160 to releasably secure the cover 136 to the base 134. In alternative examples, the moveable tab 162 may be coupled to a second side wall 105 of the cover 136 and a non-moveable tab 160 may be coupled to a second side wall 105 of the base 134. In some embodiments, one or more locking tabs 158 may be coupled to one or both first side walls 103 and/or one or more locking tabs 158 may be coupled to one or both second side walls 105. In some embodiments, the moveable tab 162 and the cover 136 are integrally joined. In some embodiments, the non- moveable tabs 160 and the base 134 are integrally joined. In some examples, substrate holder 101 can include multiple locking tabs 158 (e.g., at least 2, 3, 4, or 5 locking tabs 158). In some embodiments, the substrate holder 101 includes one locking tab 158 and one locking tab 107. In some embodiments, the substrate holder 101 includes one locking tab 158 and a pair of locking tabs 107. In some embodiments, the substrate holder 101 includes one locking tab 158 and three locking tabs 107. In some embodiments, the substrate holder 101 includes one locking tab 158 and four locking tabs 107.
As shown in FIG. 1, a surface of substrate 110 is exposed through a plurality of apertures 104 of the substrate holder 101. The plurality of apertures 104 are defined by the
top surface 102 of cover 136. The plurality of apertures 104 align with the plurality of openings of the gasket when the support device 100 is in the closed position.
FIG. 2 is a perspective view of the substrate holder 101 of FIG. 1 in an open position. The substrate holder 201 includes the locking tab 258 including a moveable tab 262 having a length Zm and a non-moveable tab 260 having a length In. The substrate holder 201 includes the pair of locking tabs 207 each including a moveable tab 206 having a length / ’m and a non- moveable tab 208 having a length / ’n. A length of the locking tab 258 can be greater than a length of the pair of locking tabs 207. For example, the length Zm of the moveable tab 262 can be greater than the length / ’m of the moveable tab 206. In some embodiments, the length Zm of the moveable tab 262 can be about 40% greater than the length / ’m of the moveable tab 206. In some embodiments, the length Zm of the moveable tab 262 can be at least about 10% to about 80% (e.g., between about 10% to 20%, 20% to 30%, 30% to 40%, 40% to 50%, 50% to 60%, 60% to 70%, or 70% to 80%) greater than the length Z ’m of the moveable tab 206. The length Zn of the non-moveable tab 260 can be greater than the length Z ’n of the non-moveable tab 208. In some embodiments, the length Zn of the non-moveable tab 260 can be about 40% greater than the length Z’n of the non-moveable tab 208. In some embodiments, the length Zn of the moveable tab 260 can be at least about 10% to about 80% (e.g., between about 10% to 20%, 20% to 30%, 30% to 40%, 40% to 50%, 50% to 60%, 60% to 70%, or 70% to 80%) or more greater than the length Z’n of the moveable tab 208.
In some embodiments, the length Zm of the moveable tab 262 is about equal to the length Zg of the gasket 224 or the length Zg of the gasket 224. In some embodiments, the length Zm of the moveable tab 262 can be about 5% greater than the length Zg of the gasket 224. In some embodiments, the length Zm of the moveable tab 262 can be at least about 5% to about 20% (e.g., between about 5% to 10%, 10% to 15%, 15% to 20%) greater than the length Zg of the gasket 224. In some embodiments, the length Zm of the moveable tab 262 is aligned with a length Zg of the gasket 224. In some embodiments, the length Z of the moveable tab 262 is at least 90% of the length Zg of the gasket 224, e.g., at least 75%, 80%, 90%, 100%, 120%, or at least 150% of the length Zg of the gasket 224, from about 75% to about 150% of the length Zg of the gasket 224. In some embodiments, the length Zm of the moveable tab 262relative to the length Zg of the gasket 224 is about 1 :0.9 to about 1: 1.1, about 1 :0.8 to about 1: 1.2, about 1:0.5 to about 1 : 1.5. The length Zm of the moveable tab 262 can help secure the gasket 224 when substrate holder 201 is in a closed position such that a force is exerted onto gasket wall 209, along the length Zg of the gasket 224. In some embodiments, moveable tab 262 is centered about the gasket 224 (e.g., centered along the length Zmof gasket 224). The relatively
larger length of the locking tab 258 compared to the length of the locking tab 207 can allow the force exerted onto the gasket wall 209 to be more easily distributed across an entire length of the gasket 224. In addition, the relatively larger length of the locking tab 258 can allow a user to more easily manipulate the locking tab 258 (e.g., for locking or releasing the locking tab 258).
In FIG. 2, the cover 236 and base 234 are pivotably connected by a pair of hinges 216 that extend from a second side wall 205 of the cover 236 to a second side wall 205 of the base 234. In some embodiments, there are no hinges. In some embodiments, the pair of hinges can be a pair of living hinges. In some embodiments, the cover and base are pivotably connected by at least one hinge. In some embodiments, one or more hinges can extend from a second side wall of the cover to a second side wall of the base. In some embodiments, the cover and the base can be pivotably connected by one hinge that has a length spanning about 50% or more of the length of the side from which it extends from. In some embodiments, the cover and the base are pivotably connected by several hinges. In some embodiments, if there are hinges present the hinges are breakable, such that the cover and the base are separable upon breaking the one or more hinges.
FIG. 2 shows the substrate holder 201 in an open position, having the cover 236 in an extended, unfolded position away from the base 234. In some embodiments, the substrate holder 201 is in an open position when the cover 236 is at about 180° with respect to the base 234, as shown in FIG. 2. In some embodiments, the substrate holder 201 is in an open position when the cover 236 is at an angle ranging from about 10° to about 170° with respect to the base 234.
The cover 236 has a bottom surface 232 from which a plurality of ribs 218 can extend perpendicularly from. In some embodiments, the cover 236 is configured to receive the gasket 224. In some embodiments, a gasket 224 can withstand at least about 10% compression set. In some embodiments, the gasket 224 can withstand about 15% or more compression set. In some embodiments, the gasket 224 can withstand about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 40%, 60%, 70% or more compression set. As used herein, compression set is expressed as the percentage of the original specimen thickness after being exposed to a constant compressive force. In some embodiments, the gasket 224 is co-molded with a portion of the substrate holder such as, for example, the cover 236. In some embodiments, the gasket 224 can withstand a compression force that results in a gasket height hg change of about 0.5 millimeters (mm). In some embodiments, the gasket 224 can withstand a compression force that results in a gasket height h& change of about 0.1 mm, 0.2
mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1 mm or more. In some embodiments, the gasket 224 is constructed out of a thermoplastic polymer, such as a thermoplastic elastomer. In some embodiments, the gasket 224 removably adheres to the bottom surface 232 of the cover 236.
The gasket 224 can include a plurality of openings 238. In some embodiments, the plurality of openings 238 can align with the plurality of apertures 104 defined by the surface of the cover 236. For example, in some embodiments, the plurality of openings 238 is positioned so that when the substrate 110 (shown in FIG. 1) rests on top of the substrate holder 201, and the substrate holder 201 is in a closed position, the plurality of apertures 104 are aligned with the plurality of openings 238. In some embodiments, the gasket 224 applies pressure on the substrate 210 when substrate holder 201 is in a closed position. The plurality of ribs 218 can be configured to support the substrate 210 and the gasket 224. In some embodiments, the gasket 224 is positionally aligned on the surface of the cover 236 by the plurality of ribs. In some embodiments, the gasket 224 is positioned so that when the substrate 210 rests on top of the substrate holder 201, and the substrate holder 201 is in the closed position, a vapor-tight seal is formed between the gasket 224 and the substrate 210. In some embodiments, an air-tight seal is formed between the gasket 224 and the substrate 210. In some embodiments, the gasket 224 is configured to prevent fluid transport between the plurality of openings 238 when the cover 236 is in the closed position.
Moveable tab 262 includes a top portion 268 extending from a substantially vertical wall 270 that further extends from the cover 236. The vertical wall 270 engages with the main body of the non-moveable tab 260 (e.g., its mating part) when the substrate holder 201 is in a closed position. The top portion 268 extends outwardly away from the main body of moveable tab 262 to form a gripping handle for the user. In some embodiments, the gripping handle may facilitate pulling or pushing of moveable tab 262 by the user (e.g., when engaging and/or disengaging non-moveable tab 260). The top portion 268 extends outwardly away from the main body of moveable tab 262 at an angle a, with respect to a horizontal plane that is parallel to the bottom surface 232 of cover 236. In some embodiments, angle a can be about 15 degrees. In some embodiments, angle a can be at least about 5 degrees to about 90 degrees or more (e.g., between about 5 degrees to 10 degrees, 10 degrees to 15 degrees, 15 degrees to 20 degrees, 20 degrees to 25 degrees, 25 degrees to 30 degrees, 30 degrees to 35 degrees, 35 degrees to 40 degrees, 40 degrees to 45 degrees, 45 degrees to 50 degrees, 50 degrees to 55 degrees, 55 degrees to 60 degrees, 60 degrees to 65 degrees, 65
degrees to 70 degrees, 70 degrees to 75 degrees, 75 degrees to 80 degrees, 80 degrees to 85 degrees, 85 degrees to 90).
A first height hm includes a top portion 268 and vertical wall 270 of moveable tab 262. A second height hv includes the vertical wall 270 of moveable tab 262. In some embodiments, a first height h of the moveable tab 262 is about equal to the height hg of the gasket 224. In some embodiments, the first height h of the moveable tab 262 can be about 5% greater than the height hg of the gasket 224. In some embodiments, the first height hm of the moveable tab 262 can be at least about 5% to about 20% (e.g., between about 5% and 10%, 10% and 15%, 15% and 20%) greater than the height hg of the gasket 224. The first height hm of the moveable tab 262 can help secure the gasket 224 when substrate holder 201 is in a closed position such that a force is exerted onto the gasket wall 209 adjacent to the locking tab 258.
In some embodiments, a second height h of the moveable tab 262 can be about equal to the height hg of the gasket 224. In some embodiments, the second height hv of the moveable tab 262 can be about 5% greater than the height hg of the gasket 224. In some embodiments, the second height h? of the moveable tab 262 can be at least about 5% to about 20% (e.g., between about 5% and 10%, 10% and 15%, 15% and20%) greater than the height hg of the gasket 224. The second height hv of the moveable tab 262 can help secure the gasket 224 when substrate holder 201 is in a closed position such that a force is exerted onto the gasket wall 209 adjacent to the locking tab 258.
In the example shown in FIG. 2, the moveable tabs 206 each include a corresponding opening 281, and the moveable tab 262 includes an opening 282. The openings 281 and the opening 282 are vertically extended openings within which the non-moveable tabs 208, 260 engage with the moveable tabs 206 in the closed position of the substrate holder 201. The non-moveable tabs 208, 260 protrude horizontally outwardly from side walls of the base 234 (e.g., the first side wall 103 shown in FIG. 1). Because the non-moveable tabs 208, 260 protrude horizontally outward, the non-moveable tabs 208, 260 contact portions of the moveable tabs 206, 262 as the substrate holder 201 is moved from the open position (FIG. 2) to the closed position (FIG. 1).
For example, the non-moveable tabs 208 contact sloped portions 271 of the moveable tabs 206 and the non-moveable tabs 260 contact a sloped portion 272 of the moveable tab 262 as the cover 236 and the base 234 are brought toward one another to move the substrate holder 201 from the open position (FIG. 2) to the closed position (FIG. 1). This contact causes the moveable tabs 206, 262 to deflect outwardly, allowing the non-moveable tabs 208,
260 to move beyond the sloped portions 271, 272 of the moveable tabs 206, 262 into the openings 281, 282. In some embodiments, to facilitate deflection of the moveable tab 262, the user can operate the gripping handle of the moveable tab 262. Once the non-moveable tabs 208, 260 move beyond the sloped portions 271, 272 into the openings 281, 282, the moveable tabs 206, 262 return toward their neutral positions such that surfaces of the moveable tabs 206, 262 defining the openings 281, 282 are configured to contact the horizontally protruding portions of the non-moveable tabs 206, 262. This creates a locking engagement between the non-moveable tabs 208, 260 and the moveable tabs 206, 262 that prevents the base 234 and the cover 236 from being moved away from one another. When the non-moveable tabs 208, 260 are positioned within the openings 281, 282, the substrate holder 201 is in the closed position. In the closed position of the substrate holder, the gasket 224 contacts (e.g., is compressed against) the substrate and provides a fluid tight seal between the sample regions of the substrate. In the example shown in FIG. 2, the substrate holder 201 includes a plurality of ribs extending perpendicularly or protruding outwardly from bottom surface 232. The gasket 224 does not come in contact (i.e., does not abut) the plurality of ribs 218. In some embodiments, the gasket is not co-molded with the cover. The gasket is mounted to the cover in another appropriate manner. In such embodiments, one or more ribs can be in proximity to or abut one or more gasket walls to help retain the gasket in a proper position. In some embodiments, when the gasket is not co-molded with the cover, one or more ribs can be in proximity to or abut 1, 2, 3, or 4 of the gasket walls. In some embodiments, the plurality of ribs 218 frame an area of the bottom surface 232 (e.g., an area that is sufficiently sized and configured to receive the gasket 224). The plurality of ribs 218 can be disposed parallel to the second side walls 205. In some embodiments, the gasket is co-molded with the cover.
The plurality of ribs 218 has a width w. In some embodiments, the plurality of ribs 218 can have an equal width w, as shown in FIG. 2. In some embodiments, the widths of the plurality of ribs 218 can vary. One of ribs 218 extends substantially perpendicular from bottom surface 232 near a first end 21 la of substrate holder 201. The remaining ribs 218 extend perpendicular from bottom surface 232 near a second end 211b of substrate holder 201. In some embodiments, the substrate holder 201 may include multiple ribs (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10 or more ribs). In some embodiments, the substrate holder 201 can include one or more ribs that extend perpendicular to the plurality of ribs 218.
The plurality of ribs 218 has a height h. In some embodiments, the plurality of nbs 218 can have an equal height h, as shown in FIG. 2. In some embodiments, a height h can be provided such that the top edge of the plurality of ribs 218 comes in contact with substrate
110 (shown in FIG. 1) when the support device is in the closed position (FIG. 1). In embodiments in which the gasket 224 is compressed against the substrate 110, the contact between the plurality of ribs 218 and the substrate 110 can define a maximum amount of compression of the gasket 224. In particular, further compression of the gasket 224 can be prevented when the top edge of the plurality of ribs 218 contacts the substrate 110. In some embodiments, the plurality of ribs 218 secures substrate 110 by coming in contact with a surface of substrate 110 when the support device is in the closed position (FIG. 1). In some embodiments, the first surface 228 of the substrate 110 engages with at least one of the plurality of ribs 218 when the substrate holder 101 is in the closed position (FIG. 1). In some embodiments, the first surface 228 of the substrate 110 includes a sample region. In some embodiments, the sample region is an area of the substrate that is configured to receive one or more samples. In some embodiments, substrate 110 includes one or more sample regions.
FIG. 3 is an exploded view of an exemplary support device 300 in an open position. Cover 336 is configured to receive gasket 324. The cover 336 defines four holes 342 that receive four feet 344 of gasket 324. Each foot 344 projects from a bottom surface 366 of the gasket 324. In some embodiments, each foot 344 projects from a comer of the gasket 324 (e.g., when two of the gasket walls 309 meet and form a right angle) or near a comer of the gasket 324. The feet 344 can be composed of a pliable or flexible material (e.g., a polymeric material such as silicone). In some embodiments, the feet 344 have a circular base having a diameter that is larger than a diameter of the holes 342. The feet 344 are configured to partially or completely deform in shape when being introduced into the holes 342 such that once inserted, the feet 344 are secured and not easily removed due to the difference in diameters of the circular base of the feet 344 and the holes 342. In some embodiments, the gasket 324 is permanently attached to the cover 336. In some embodiments, gasket 224 can be reversibly attached to cover 336.
Gasket 324 includes an L-shaped projection 326 extending from one of the gasket walls 309. In some embodiments, the L-shaped projection 326 extends from a comer of the gasket 324. In some embodiments, the L-shaped projection 326 is configured to be received by a recess 340 defined by the cover 336, In some embodiments, the recess 340 is an L- shaped recess. In some embodiments, the recess 340 has a shape that is complementary to the shape of the L-shaped projection 326.
The cover 336 includes a plurality of T-shaped ribs 346 and cross-shaped ribs 348 extending perpendicularly or protruding outwardly from the bottom surface 332 of cover 336. In some embodiments, the cover 336 includes eight T-shaped ribs 346. In some
embodiments, the cover 336 includes at least about one to about eight T-shaped ribs 346 (e.g., 1, 2, 3, 4, 5, 6, 7, or 8 T-shaped ribs 346). The T-shaped ribs 346 can extend perpendicularly or protrude outwardly from a portion of the bottom surface 332 that is aligned with the length /g of the gasket 324. The T-shaped ribs 346 can extend perpendicularly or protrude outwardly from a portion of the bottom surface 332 that is aligned with the width wg of the gasket 324. In some embodiments, the cover 336 includes at least about one to about three cross-shaped ribs 348 (e.g., 1, 2 or 3 cross-shaped ribs 348). The cross-shaped ribs 348 can extend perpendicularly or protrude outwardly from a portion of the bottom surface 332 where four apertures 304 intersect.
FIG. 4 is a perspective view of the support device 400 including the substrate holder 401 and the substrate 410. The substrate holder 401 is shown as having the cover 436 detached from the base 434. The pair of hinges 416 can be breakable hinges. In some embodiments, the pair of hinges 416 are selectively, manually severable to permit a user to detach cover 436 from base 434. In some embodiments, the pair of hinges 416 can include a breakable portion. In some embodiments, the breakable portion can include breakable webbing. In some embodiments, the pair of hinges 416 is irreversibly breakable. For example, once broken, the cover 436 and base 434 cannot be attached via the pair of hinges 416. In some embodiments, the pair of hinges 416 may be reversibly breakable. For example, in some embodiments the pair of hinges 416 may include first portions 450 and second portions 452 that can be configured to reversibly engage with one another. In some embodiments, the first portions 450 of hinges 416 integrally extend from the cover 436 and the second portions 452 of hinge 416 integrally extend from the base 434. In some embodiments, the first and second portions 450, 452 can be directly engaged to each other via a fastener (e.g., a snap fit, force fit, or male and female connections). In some embodiments, no hinges 416 are present on the device.
In some embodiments, one or more sample regions 464 defined on the first surface 428 of substrate 410 can fall within the enclosed area defined by each one of the plurality of openings 438 of gasket 424. In some embodiments, substrate 410 may include samples (e.g., biological material samples) on a portion of its surface that align with one or more of the plurality of openings 438. In some embodiments, the samples (e.g., biological material samples) may be identified in the same manner as the corresponding aperture of the plurality of openings 438.
In some embodiments, the base 434 is configured to receive substrate 410. When the substrate holder 401 is in a closed position, the cover 436 is configured to be placed on top of
the base 434 to secure the substrate 410 and the gasket 424 between the cover 436 and the base 434. In some embodiments, a user detaches the cover 436 from the base 434 before placing the substrate 410 in the base 434. Once detached, the user can insert the substrate 410 into the base 434 following the direction of the arrow 414. The user can place the cover 436 on top of the base 434 holding the substrate 410, e.g., in the direction of arrow 412, and snap the cover 436 onto the base 434 via the locking tabs 407 and 458 to secure the substrate 410.
In some examples, the second surface of the substrate 410 can rest on a portion of the base 434 of the substrate holder 401. For example, base 434 can include a lip 422 configured to retain the substrate 410 within the base 434. For example, substrate 410 can rest on lip 422 and be held in place. In some embodiments, lip 422 extends around the perimeter of the base 434. In some embodiments, the substrate can be secured to the base of the substrate holder. In an example, the substrate 410 can be placed in the base 434 in the direction of arrow 414. The second surface of substrate 410 can be placed such that it comes in contact with lip 222 and the first surface 428 of substrate 410 comes in contact with the plurality of ribs 418 and gasket 424 when the support device 400 is in a closed position. In some embodiments, substrate 410 can be loaded into base 434 without using a tool. The base 434 can include an opening 420 sufficiently sized to expose one or more portions of the substrate 410. In some embodiments, opening 420 is sized such that the majority of the second surface of substrate 410 is exposed and not covered. In some embodiments, opening 420 can enable the second surface of substrate 410 to come in contact with a surface of a heating device (e g., a plate 3110, as described in PCT/US2019/065100, the entire contents of which are incorporated herein by reference). In some embodiments, the first surface 428 of substrate 410 includes a sample region 464. In some embodiments, the base 434 includes opening 420 that exposes at least a portion of the second surface of the substrate 410 when the substrate 410 is placed in the base 434.
In some embodiments, moveable tabs 406 and 458 can have a C-shape structure. In some embodiments, moveable tabs 406 and 458 are constructed from a flexible material that enables them to be flexed away from the body of the substrate holder in order to engage the non-moveable tabs 408 and 462, respectively. In some embodiments, non-moveable tabs 408 and 462 are unable to be flexed. In some embodiments, non-moveable tabs 408 and 462 are rigid and do not flex when engaging the moveable tabs 406, 458.
In some embodiments, a first side wall 403 can measure about 3 inches. In some embodiments, a second side wall 405 can measure about 1 inch. In some embodiments, substrate 410 can measure about 75 millimeters (mm) by 25 mm. In some embodiments,
substrate 410 can measure about 75 millimeters (mm) by 50 mm. In some embodiments, substrate 410 can measure about 48 millimeters (mm) by 28 mm. In some embodiments, substrate 410 can measure about 46 millimeters (mm) by 27 mm. In some embodiments, substrate 410 is a glass slide.
A support device may be substantially similar in construction and function in several aspects to the support device 100, 200, 300, 400 discussed above, but can include an alternative number, size, and shape of apertures defined by the cover and an alternative number, size, and shape of gasket openings instead of the plurality of apertures 104, 304 and the plurality of openings 138, 238, 338, 438. In some embodiments, the support device may have two apertures. In some embodiments, the support device may have two gasket openings. Such difference between the number, size, and shape of apertures and gasket openings can allow a user to use the substrate holder to support substrates having a wide variety of number, size, and shape of sample regions defined on the surface of the substrate.
FIG. 5 illustrates an example support device 500 in a closed position with two exemplary aperatures. The support device 500 includes a first aperture 554a and a second aperture 554b. The support device 500 includes two gasket openings that align with the first and second apertures 554a, 554b and enable portions of the substrate 510 to be exposed when the substrate holder 501 is in a closed position. In some embodiments, the support device 500 can include a cover 536 defining 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, or more apertures. In some embodiments, the support device 500 includes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, or more gasket openings. In some embodiments, the support device 500 can include a cover 536 defining a number of apertures ranging between 1 and 4, between 4 and 8, between 8 and 16, or between 16 and 20. In some embodiments, the support device 500 includes a number of gasket openings ranging between 1 and 4, between 4 and 8, between 8 and 16, or between 16 and 20.
In an aspect, the present disclosure includes a method of incubating a sample disposed on a sample region of any of the substrates disclosed herein. In some embodiments, the method includes mounting the substrate on any of the support devices disclosed herein. The method further includes positioning the substrate and support device on a heating apparatus (e.g., a laboratory heat plate). The method further includes activating the heating apparatus to transfer heat to the sample (e.g., via the second surface of the substrate that is exposed via the opening of the substrate holder). In some embodiments, when the substrate holder is coupled to the support device, at least 60% of a sample region is overlaid by the support device. In
some embodiments, at least 50%, 40%, 30%, 20%, 10% or less of a sample region of a substrate is overlaid by the support device.
While embodiments shown in FIGS. 1-4 show non-moveable tabs (e.g., the nonmoveable tabs 108, 160, 208, 260, 408, 462) on the base (e.g., the base 134, 234, 334, 434) and the moveable tabs (e.g., the moveable tabs 106, 162, 206, 262, 406, 460) on the cover (e.g., the cover 136, 236, 436), in further embodiments, the non-moveable tabs are on the cover and the moveable tabs are on the base.
OTHER EMBODIMENTS
It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims.
Disclosed are systems, apparatuses (e.g., devices), and methods that can be used for, can be used in conjunction with, can be used in preparation for, or are products of the disclosed methods. These and other systems, apparatuses, and methods are disclosed herein, and it is understood that combinations, subsets, interactions, groups, etc. of these systems, apparatuses, and methods are disclosed. That is, while specific reference to each various individual and collective combinations and permutations of these systems, apparatuses and methods may not be explicitly disclosed, each is specifically contemplated and described herein. For example, if a particular system, apparatus, or a particular method is disclosed and discussed and a number of systems, apparatuses, or methods are discussed, each and every combination and permutation of the systems, apparatuses, and the methods are specifically contemplated unless specifically indicated to the contrary. Likewise, any subset or combination of these is also specifically contemplated and disclosed.
Other aspects, advantages, and modifications are within the scope of the following claims.
Claims
1. A support device comprising: a substrate holder comprising: a cover comprising opposing first side walls, the cover configured to receive a gasket; a base comprising opposing first side walls, the base configured to receive a sample substrate; and a first locking tab and a second locking tab, the first and second locking tabs comprising moveable tabs coupled to the first side walls of one of the cover and the base and non-moveable tabs coupled to the first side walls of the other of the cover and the base, the first locking tab having a length greater than a length of the second locking tab, wherein the first locking tab extends along a length of the gasket, and wherein the moveable tabs are configured to engage with the non-moveable tabs to releasably secure the cover to the base.
2. The support device of claim 1, wherein a height of the first locking tab is about equal to a height of the gasket.
3. The support device of claim 1, wherein the length of the first locking tab is about equal to the length of the gasket.
4. The support device of claim 1, wherein the sample substrate rests on top of the base of the substrate holder.
5. The support device of claim 1, wherein the cover comprises a plurality of ribs extending from a surface of the cover, and wherein the gasket is positionally aligned on the surface of the cover by the plurality of ribs.
6. The support device of claim 1, wherein the gasket is positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, a vapor-tight seal is formed between the gasket and the sample substrate.
33
7. The support device of claim 1, wherein the cover comprises at least two apertures.
8. The support device of claim 7, wherein the gasket comprises at least two openings, wherein the at least two openings are positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, the at least two apertures are aligned with the at least two openings.
9. The support device of claim 8, wherein the gasket is configured to prevent fluid transport between the at least two openings when the cover is in the closed position.
10. The support device of claim 1, wherein the base comprises a lip extending around a perimeter of the base, the lip configured to retain the sample substrate within the base.
11. The support device of claim 1, wherein the cover comprises a plurality of ribs extending from a surface of the cover, and wherein the sample substrate engages with at least one of the plurality of ribs when the substrate holder is in a closed position.
12. The support device of claim 1, wherein the base comprises an opening exposing at least a portion of the sample substrate when the sample substrate is placed in the base.
13. The support device of claim 1, wherein each of the first side walls of the cover is generally orthogonal to a second side wall of the cover.
14. The support device of claim 1, wherein when the substrate holder is in a closed position, the cover is configured to fold onto the base.
15. The support device of claim 1, wherein the length of the first locking tab is at least 90% of the length of the gasket.
16. A support device comprising: a substrate holder comprising: a cover comprising opposing first side walls and opposing second side walls, the cover configured to receive a gasket;
34
a base comprising opposing first side walls and opposing second side walls, the base configured to receive a sample substrate, each of the first side walls of the base and the cover being longer than each of the second side walls of the base and the cover; and a locking tab comprising a moveable tab and a non-moveable tab, one of the moveable tab and the non-moveable tab coupled to one of the first side walls of the cover, and another of the moveable tab and the non-moveable tab coupled to one of the first side walls of the base, the locking tab having a length about equal to a length of the gasket, wherein the locking tab extends along the length of the gasket.
17. The support device of claim 16, wherein the sample substrate rests on top of the base of the substrate holder.
18. The support device of claim 16, wherein the cover comprises a plurality of ribs extending from a surface of the cover, and the gasket is positionally aligned on the surface of the cover by the plurality of ribs.
19. The support device of claim 16, wherein the gasket is positioned so that when the sample substrate is secured by the substrate holder, and the substrate holder is in a closed position, a vapor-tight seal is formed between the gasket and the sample substrate.
20. The support device of claim 16, wherein the cover comprises one aperture.
21. The support device of claim 16, wherein the cover comprises at least two apertures.
22. The support device of claim 21 , wherein the gasket comprises at least two openings, wherein the at least two openings is positioned so that when the sample substrate is secured by the substrate holder and the substrate holder is in a closed position, the at least two apertures is aligned with the at least two openings.
23. The support device of claim 22, wherein the gasket is configured to prevent fluid transport between the at least two openings when the substrate holder is in the closed position.
24. The support device of claim 16, wherein the sample substrate comprises a glass slide.
25. The support device of claim 16, wherein the base comprises a lip extending around a perimeter of the base, the lip configured to retain the sample substrate within the base.
26. The support device of claim 16, wherein the cover comprises a plurality of ribs extending from a surface of the cover, and the sample substrate engages wi th at least one of the plurality of ribs when the substrate holder is in a closed position.
27. The support device of claim 16, wherein the base comprises an opening exposing at least a portion of the sample substrate when the sample substrate is placed in the base.
28. The support device of claim 16, wherein each of the first side walls of the cover is generally orthogonal to the second side walls of the cover.
29. The support device of claim 16, further comprising at least one breakable hinge extending from one of the second side walls of the cover to one of the second side walls of the base such that, when the substrate holder is in a closed position, the cover is configured to fold onto the base to secure the sample substrate and the gasket between the cover and the base.
30. The support device of claim 29, wherein the cover and the base are pivotably connected by at least one hinge extending from one of the second side walls of the cover to one of the second side walls of the base such that when the substrate holder is in the closed position, the cover configured to fold over the base to secure the sample substrate and the gasket between the cover and the base.
31. The support device of claim 29, wherein the cover and the base are pivotably connected by the at least one breakable hinge.
32. A method of incubating a sample disposed on a sample region of a substrate, the method comprising:
mounting the substrate on a base of a substrate holder of a support device, the substrate comprising the sample; moving a cover of the substrate holder toward the base of the substrate holder such that first and second moveable tabs on one of the base and the cover engage with first and second non-moveable tabs on the other of the base and the cover, the first moveable tab having a length greater than a length of the second moveable tab and extending along a length of a gasket received by the cover; positioning the substrate and the support device on a heating apparatus; and activating the heating apparatus to transfer heat to the sample.
33. The method of claim 32, wherein the substrate comprises a glass slide.
34. The method of claim 32, wherein, when the substrate holder is coupled to the support device, at least 60% of the sample region is overlaid by the support device.
35. The method of claim 32, wherein a height of the first moveable tab is about equal to a height of the gasket.
36. The method of claim 32, wherein a length of the first moveable tab is about equal to a length of the gasket.
37
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063110833P | 2020-11-06 | 2020-11-06 | |
US63/110,833 | 2020-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022098810A1 true WO2022098810A1 (en) | 2022-05-12 |
Family
ID=78806707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2021/057972 WO2022098810A1 (en) | 2020-11-06 | 2021-11-04 | Assay support devices |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN217033310U (en) |
WO (1) | WO2022098810A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11390912B2 (en) | 2015-04-10 | 2022-07-19 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11401545B2 (en) | 2010-04-05 | 2022-08-02 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11407992B2 (en) | 2020-06-08 | 2022-08-09 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11408029B2 (en) | 2020-06-25 | 2022-08-09 | 10X Genomics, Inc. | Spatial analysis of DNA methylation |
US11434524B2 (en) | 2020-06-10 | 2022-09-06 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
US11479809B2 (en) | 2011-04-13 | 2022-10-25 | Spatial Transcriptomics Ab | Methods of detecting analytes |
US11560593B2 (en) | 2019-12-23 | 2023-01-24 | 10X Genomics, Inc. | Methods for spatial analysis using RNA-templated ligation |
US11592447B2 (en) | 2019-11-08 | 2023-02-28 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
US11608520B2 (en) | 2020-05-22 | 2023-03-21 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
US11618897B2 (en) | 2020-12-21 | 2023-04-04 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
US11618918B2 (en) | 2013-06-25 | 2023-04-04 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11624086B2 (en) | 2020-05-22 | 2023-04-11 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11733238B2 (en) | 2010-04-05 | 2023-08-22 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11739381B2 (en) | 2021-03-18 | 2023-08-29 | 10X Genomics, Inc. | Multiplex capture of gene and protein expression from a biological sample |
US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11933957B1 (en) | 2018-12-10 | 2024-03-19 | 10X Genomics, Inc. | Imaging system hardware |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391937B1 (en) | 1998-11-25 | 2002-05-21 | Motorola, Inc. | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
US20090253582A1 (en) * | 2006-06-29 | 2009-10-08 | Ge Healthcare Bio-Sciences Ab | Chamber apparatus |
US20100151511A1 (en) * | 2008-10-28 | 2010-06-17 | Millipore Corporation | Biological culture assembly |
US20100267590A1 (en) * | 2002-01-22 | 2010-10-21 | Grace Bio-Labs, Inc. | Reaction Surface Array Diagnostic Apparatus |
US9512422B2 (en) | 2013-02-26 | 2016-12-06 | Illumina, Inc. | Gel patterned surfaces |
US20170253918A1 (en) | 2016-03-01 | 2017-09-07 | Expansion Technologies | Combining protein barcoding with expansion microscopy for in-situ, spatially-resolved proteomics |
US9889422B2 (en) | 2004-01-07 | 2018-02-13 | Illumina Cambridge Limited | Methods of localizing nucleic acids to arrays |
US20180052081A1 (en) | 2016-05-11 | 2018-02-22 | Expansion Technologies | Combining modified antibodies with expansion microscopy for in-situ, spatially-resolved proteomics |
US20180156784A1 (en) | 2016-12-02 | 2018-06-07 | The Charlotte Mecklenburg Hospital Authority d/b/a Carolinas Healthcare Syetem | Immune profiling and minimal residue disease following stem cell transplanation in multiple myeloma |
US20200298241A1 (en) * | 2019-03-19 | 2020-09-24 | Miltenyi Biotec B.V. & Co. KG | Slide chamber |
WO2020219901A1 (en) * | 2019-04-26 | 2020-10-29 | 10X Genomics, Inc. | Imaging support devices |
-
2021
- 2021-11-04 WO PCT/US2021/057972 patent/WO2022098810A1/en active Application Filing
- 2021-11-08 CN CN202122725896.8U patent/CN217033310U/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391937B1 (en) | 1998-11-25 | 2002-05-21 | Motorola, Inc. | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
US20100267590A1 (en) * | 2002-01-22 | 2010-10-21 | Grace Bio-Labs, Inc. | Reaction Surface Array Diagnostic Apparatus |
US9889422B2 (en) | 2004-01-07 | 2018-02-13 | Illumina Cambridge Limited | Methods of localizing nucleic acids to arrays |
US20090253582A1 (en) * | 2006-06-29 | 2009-10-08 | Ge Healthcare Bio-Sciences Ab | Chamber apparatus |
US20100151511A1 (en) * | 2008-10-28 | 2010-06-17 | Millipore Corporation | Biological culture assembly |
US9512422B2 (en) | 2013-02-26 | 2016-12-06 | Illumina, Inc. | Gel patterned surfaces |
US20170253918A1 (en) | 2016-03-01 | 2017-09-07 | Expansion Technologies | Combining protein barcoding with expansion microscopy for in-situ, spatially-resolved proteomics |
US20180052081A1 (en) | 2016-05-11 | 2018-02-22 | Expansion Technologies | Combining modified antibodies with expansion microscopy for in-situ, spatially-resolved proteomics |
US20180156784A1 (en) | 2016-12-02 | 2018-06-07 | The Charlotte Mecklenburg Hospital Authority d/b/a Carolinas Healthcare Syetem | Immune profiling and minimal residue disease following stem cell transplanation in multiple myeloma |
US20200298241A1 (en) * | 2019-03-19 | 2020-09-24 | Miltenyi Biotec B.V. & Co. KG | Slide chamber |
WO2020219901A1 (en) * | 2019-04-26 | 2020-10-29 | 10X Genomics, Inc. | Imaging support devices |
Non-Patent Citations (2)
Title |
---|
ECHEVERRIA ET AL., GELS, vol. 4, 2018, pages 54 |
WILLNER, ACC. CHEM. RES., vol. 50, 2017, pages 657 - 658 |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11634756B2 (en) | 2010-04-05 | 2023-04-25 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11401545B2 (en) | 2010-04-05 | 2022-08-02 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11866770B2 (en) | 2010-04-05 | 2024-01-09 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11767550B2 (en) | 2010-04-05 | 2023-09-26 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11761030B2 (en) | 2010-04-05 | 2023-09-19 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11479810B1 (en) | 2010-04-05 | 2022-10-25 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11732292B2 (en) | 2010-04-05 | 2023-08-22 | Prognosys Biosciences, Inc. | Spatially encoded biological assays correlating target nucleic acid to tissue section location |
US11733238B2 (en) | 2010-04-05 | 2023-08-22 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11519022B2 (en) | 2010-04-05 | 2022-12-06 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11542543B2 (en) | 2010-04-05 | 2023-01-03 | Prognosys Biosciences, Inc. | System for analyzing targets of a tissue section |
US11549138B2 (en) | 2010-04-05 | 2023-01-10 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11560587B2 (en) | 2010-04-05 | 2023-01-24 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US11788122B2 (en) | 2011-04-13 | 2023-10-17 | 10X Genomics Sweden Ab | Methods of detecting analytes |
US11479809B2 (en) | 2011-04-13 | 2022-10-25 | Spatial Transcriptomics Ab | Methods of detecting analytes |
US11795498B2 (en) | 2011-04-13 | 2023-10-24 | 10X Genomics Sweden Ab | Methods of detecting analytes |
US11821024B2 (en) | 2013-06-25 | 2023-11-21 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11618918B2 (en) | 2013-06-25 | 2023-04-04 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11753674B2 (en) | 2013-06-25 | 2023-09-12 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
US11613773B2 (en) | 2015-04-10 | 2023-03-28 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11390912B2 (en) | 2015-04-10 | 2022-07-19 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11739372B2 (en) | 2015-04-10 | 2023-08-29 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
US11933957B1 (en) | 2018-12-10 | 2024-03-19 | 10X Genomics, Inc. | Imaging system hardware |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11753675B2 (en) | 2019-01-06 | 2023-09-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11592447B2 (en) | 2019-11-08 | 2023-02-28 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
US11808769B2 (en) | 2019-11-08 | 2023-11-07 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
US11795507B2 (en) | 2019-12-23 | 2023-10-24 | 10X Genomics, Inc. | Methods for spatial analysis using RNA-templated ligation |
US11981965B2 (en) | 2019-12-23 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using RNA-templated ligation |
US11560593B2 (en) | 2019-12-23 | 2023-01-24 | 10X Genomics, Inc. | Methods for spatial analysis using RNA-templated ligation |
US11608520B2 (en) | 2020-05-22 | 2023-03-21 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
US11866767B2 (en) | 2020-05-22 | 2024-01-09 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
US11959130B2 (en) | 2020-05-22 | 2024-04-16 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
US11624086B2 (en) | 2020-05-22 | 2023-04-11 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
US11781130B2 (en) | 2020-06-08 | 2023-10-10 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11624063B2 (en) | 2020-06-08 | 2023-04-11 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11407992B2 (en) | 2020-06-08 | 2022-08-09 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11492612B1 (en) | 2020-06-08 | 2022-11-08 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
US11434524B2 (en) | 2020-06-10 | 2022-09-06 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
US11408029B2 (en) | 2020-06-25 | 2022-08-09 | 10X Genomics, Inc. | Spatial analysis of DNA methylation |
US11661626B2 (en) | 2020-06-25 | 2023-05-30 | 10X Genomics, Inc. | Spatial analysis of DNA methylation |
US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
US11952627B2 (en) | 2020-07-06 | 2024-04-09 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
US11618897B2 (en) | 2020-12-21 | 2023-04-04 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
US11959076B2 (en) | 2020-12-21 | 2024-04-16 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
US11970739B2 (en) | 2021-03-18 | 2024-04-30 | 10X Genomics, Inc. | Multiplex capture of gene and protein expression from a biological sample |
US11739381B2 (en) | 2021-03-18 | 2023-08-29 | 10X Genomics, Inc. | Multiplex capture of gene and protein expression from a biological sample |
Also Published As
Publication number | Publication date |
---|---|
CN217033310U (en) | 2022-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN217033310U (en) | Supporting device | |
US20240035937A1 (en) | Modular assay support devices | |
WO2020219901A1 (en) | Imaging support devices | |
US20230313279A1 (en) | Methods of determining the location of an analyte in a biological sample using a plurality of wells | |
US20210223227A1 (en) | Electrophoretic system and method for analyte capture | |
US20230017773A1 (en) | Fluid delivery methods | |
US8288120B2 (en) | Method for studying floating, living cells | |
Deiss et al. | Platform for high-throughput testing of the effect of soluble compounds on 3D cell cultures | |
EP1866075B1 (en) | Microfluidic device for studying cells | |
US20100167950A1 (en) | Microarray chip and method of fabricating for the same | |
CA2788575C (en) | Hanging drop devices, systems and/or methods | |
US8679737B2 (en) | Microfluid device and method of producing diffusively built gradients | |
EP1654347B1 (en) | Improved materials for constructing cell-chips, cell-chip covers, cell-chip coats, processed cell-chips and uses thereof | |
US20030166015A1 (en) | Multiplexed analysis of cell-substrate interactions | |
AU2008208342A1 (en) | Analysis chip and analysis method | |
EP3531128A1 (en) | Integrated platform for single cell analysis | |
US20180264466A1 (en) | Position-defined cell culture and characterization platform | |
KR101218986B1 (en) | Bio chip | |
WO2009095666A1 (en) | Microtrench and tumour proliferation assay | |
WO2004069988A1 (en) | High-density cell array board, process for producing the same and method of using the same | |
WO2018094194A1 (en) | Chip platforms for microarray 3d bioprinting | |
KR101208145B1 (en) | Bio chip | |
CN116888253A (en) | Modular measuring support device | |
CN116472116A (en) | Fluid delivery method | |
CN118086049A (en) | Three-dimensional tissue-like array chip and substance screening analysis method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21815809 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21815809 Country of ref document: EP Kind code of ref document: A1 |